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English Summary  
Cardiovascular diseases (CVDs) remain the leading cause of death worldwide with myocardial 
infarction and stroke as their main clinical manifestations. Advanced imaging techniques are required 
to gain further insight into the underlying biological processes of CVD, especially to capture in vivo 
dynamics non-invasively. Optoacoustic imaging is a biomedical imaging technology based on light 
absorption of biological tissues causing thermal expansion of molecules, which then emit detectable 
ultrasound waves. This phenomenon is known as the optoacoustic1 (OA) effect. In optoacoustic 
tomography (OAT), a single nano-second laser pulse allows volumetric imaging with optical contrast 
at centimetre-scale depths, hence serving as a valuable imaging modality for deep tissue imaging of 
rapid cardiovascular dynamics. In particular, the strong optical absorption of haemoglobin in the near-
infrared wavelength range allows detection of numerous cardiovascular structures. OAT has been 
successfully applied to study different aspects of the cardiovascular system, but is still not considered a 
standard tool for cardiovascular imaging because of technical limitations and a small number of 
preclinical and clinical studies. This thesis thus further explores potential applications and usability of 
OAT for preclinical and clinical use by capitalizing on its unique volumetric, real-time and non-invasive 
capabilities, therefore addressing current limitations in cardiovascular imaging. In particular, the 
capabilities of OAT will be assessed as a preclinical imaging modality in murine models of heart disease, 
including myocardial infarction and pulmonary heart disease. OAT will also be assessed on a human 










Herz-Kreislauferkrankungen sind die verbreitetste Todesursache weltweit. Herzinfarkt und 
Schlaganfall stellen dabei die beiden häufigsten klinischen Krankheitsbilder dar. Fortgeschrittene 
Bildgebungsverfahren werden benötigt um vertiefte Einblicke in die biologischen Prozesse hinter Herz-
Kreislauferkrankungen zu erlangen mit besonderem Augenmerk auf dynamische, nicht-invasive und in 
vivo Verfahren. Optoakustische Bildgebung ist eine biomedizinische Bildgebungstechnologie basierend 
auf der Absorption von Licht in biologischem Gewebe welche zu temporärer thermischer Expansion 
von Molekülen und damit der Entstehung von Ultraschallwellen führt, auch bekannt als der 
optoakustische Effekt. Optoakustische Tomographie (OAT) erlaubt volumetrische Bildgebung 
basierend auf einzelnen Nanosekunden Laserpulsen und verbindet optischen Kontrast mit Ultraschall 
basierter Tiefenauflösung und stellt ein vielversprechendes Bildgebungsverfahren dar um schnelle 
kardiovaskuläre Prozesse zu beobachten. Die starke optische Absorption von Hämoglobin im 
Nahinfrarot erlaubt die Detektierung verschiedener kardiovaskulärer Strukturen. OAT wurde 
erfolgreich verwendet um verschiedene Aspekte des kardiovaskulären Systems zu untersuchen und  
kann dennoch nicht als ein Standardtool in Biologie und Medizin bezeichnet werden aufgrund 
technischer Limitierungen und einer geringen Anzahl vorklinischer und klinischer Studien. In Rahmen 
dieser Arbeit wurden potentielle Anwendungen und Nutzbarkeit von OAT für vorklinische und 
klinische Verwendung erörtert. Durch die einzigartige Kombination von volumetrischer und nicht-
invasiver Bildgebung in Echtzeit konnten existierende Limitierungen in kardiovaskulärer Forschung 
überbrückt werden. Im Speziellen wurde OAT als ein vorklinisches Bildgebungsverfahren für 
Mausmodelle mit Herz-Kreislauferkrankungen wie Herzinfarkt und Lungenherz evaluiert. Die 
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Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, where myocardial 
infarction (MI) and stroke are the main clinical manifestations of CVD (Roth et al., 2017a). In the past 
decade, there has been significant progress on improving the outlook of CVD (Arnett et al., 2019); 
nevertheless, the unceasing high mortality rates only emphasize the necessity to continue advanced 
research on CVD. CVD is subject to multiple risk factors that can be considered as either modifiable 
risk factors (high cholesterol, tobacco-smoking) and non-modifiable risk factors (family history, 
gender), making research efforts particularly difficult due to the multifactorial nature of CVD (Kumar, 
2017). Heart failure is a common result of CVD, which can stem from coronary artery disease (CAD) 
that leads to MI; and also pulmonary heart disease (PHD), which develops from a non-cardiac origin 
(discussed in detail in Section 1.1). Additionally, CVD can lead to injury of the brain, commonly caused 
by a stroke (discussed in detail in Section 1.2). It is therefore crucial to explore a variety of approaches 
for elucidating CVD, including efforts in both preclinical and clinical research.  
1.1 Heart failure 
CAD is one of the main causes of HF and drives mechanical and electrical alterations within the 
myocardium causing ventricular dysfunction. The coronary arteries supply blood directly to the heart 
and in CAD, blood flow is significantly reduced causing ischemia of the myocardium. The underlying 
cause of CAD is atherosclerosis; the thickening of the arterial wall due to endothelial dysfunction, which 
will be discussed in detail in Section 1.2. Ischemia of the myocardium, most commonly known as 
myocardial infarction (MI) is the main outcome of CAD, where part of the myocardium is deteriorated 
due to the death of cardiomyocytes from lack of oxygen (Roth et al., 2017b). The reduced blood flow 
increases the workload on the heart to counteract the reduced oxygen supply. This in turn induces 
various mechanisms of ventricular dysfunction or remodelling, including hypertrophy (thickening of 
ventricular muscle), dilation (enlargement of ventricle) and arrhythmia (irregular heartbeat), as 
illustrated in Figure 1.1. These alterations in the mechanical and electrical architecture of the heart are 















Although CAD is the most common cause of HF, it is important to acknowledge the effects of non-
cardiac dysfunction on the myocardium and its influence towards HF. Various non-cardiac diseases can 
compromise the physiological function of the heart, for example, impairment of the kidneys or lungs 
(Lam et al., 2011b). Ventricular dysfunction, such as hypertrophy and arrhythmia, can commonly occur 
in response to non-cardiac diseases without the presence of HF. However, these cardiac symptoms can 
be important indicators or precursors of HF and should be understood in greater detail. The pulmonary 
circuit, which involves blood circulation between the lungs and heart is a prime example where heart 
function can be severely altered by pulmonary dysfunction. Pulmonary hypertension (PH) is such an 
example, where deteriorated lung function has large implications on heart function causing PHD.   
 
 
Figure 1.1 Schematic of healthy and diseased myocardium. A normal healthy heart (top). Dilated (left), 
hypertrophic (bottom) and arrhythmogenic (right) are examples of symptoms of a dysfunctional myocardium 




1.1.3. Myocardial infarction 
Ischemic myocardial injury is a result of a prolonged period of reduced oxygen supply to the 
myocardium, where morphological, functional and molecular changes occur in the myocardium. The 
length and severity of the ischemic event defines the patient’s prognosis, with delayed treatment times 
strongly increasing the chance of irreversible loss of cardiomyocytes, which in turn can lead to HF 
(Cho, Fernandez, & Kwon, 2014). 
1.1.3.1 Myocardial regeneration 
A major issue facing the treatment of MI is the limited regenerative capacity of the heart. Until recently 
it has been thought that the heart is a post-mitotic organ, however it has become clear that it possesses 
a small capability of renewal. Studies showed that the capacity of renewal was approximately 1% per 
annum for younger hearts, further decreasing with age (Bergmann et al., 2009). Myocardial 
regeneration following MI involves multiple complex processes including scar tissue formation, 
inflammation and angiogenesis (T. J. Cahill, Choudhury, & Riley, 2017).  
Due to the limited regeneration capabilities of the myocardial tissue, restoration of injured or dead 
cardiomyocytes would be a highly effective way for myocardial repair, thus research efforts have 
focused on different pathways to promote cardiac stem cell (CSC) repair as a possible method for 
myocardial restoration (T. J. Cahill et al., 2017) A cell surface receptor has been of particular interest 
for myocardial regeneration, known as c-kit (Ellison et al., 2013; Keith & Bolli, 2015). c-kit is a tyrosine 
kinase receptor expressed throughout the body, responsible for binding to a stem cell factor by 
activation of a downstream signalling cascade. c-kit positive (c-kit+) expression in CSCs has caused  
controversy due to the inconsistency and questionable reporting of results (Zhou & Wu, 2018). Clinical 
trials showed small improvements in cardiac function after c-kit+ transplantation, however patient 
numbers were low with  uncertainty whether improvement in cardiac function was directly a result of 
c-kit+ transplantation (Makkar et al., 2012). c-kit+ cells have an effect on cardiac regeneration after MI, 
however the basic understanding and scale of the process remains unclear. It is therefore crucial to gain 
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a deeper understanding of the c-kit effect post MI, particularly in pre-clinical models before attempting 
clinical trials (Zhou & Wu, 2018).  
1.1.4 Pulmonary heart disease  
PHD is an umbrella term for altered heart function in response to impaired respiratory function (Forfia, 
Vaidya, & Wiegers, 2013). HF can be caused by many factors that directly affect the heart, however it 
is important to take into account how pathologies of non-cardiac origins can also be an indirect cause 
of HF (Lam et al., 2011).  
1.1.4.1 Chronic pulmonary hypoxia 
A hypoxic pulmonary environment can stem from various respiratory disorders including chronic 
obstructive pulmonary disorder (COPD), sleep disordered breathing; and also from high altitudes 
(Bärtsch & Gibbs, 2007; Stenmark, Fagan, & Frid, 2006). Hypoxic conditions induce processes of 
vascular remodelling within the lungs (Stenmark et al., 2006). In acute hypoxia (short period of time 
with reduced oxygen), the pulmonary vasculature rapidly constricts in response, however when normal 
oxygen levels or normoxic conditions are returned, the effect is reversible. In chronic hypoxic 
conditions, such as in COPD, the outcome is more severe (Bärtsch & Gibbs, 2007; Blanco, Piccari, & 
Barberà, 2016). Pulmonary vasoconstriction also occurs, however unlike in acute hypoxia, the 
reversibility of the effect is limited. One of the main results of pulmonary vasoconstriction due to 
hypoxia is caused by the muscularization of otherwise non-muscular arteries resulting from increased 
smooth muscle actin (α – SMA) proliferation (Stenmark et al., 2006).  
Remodelling of the pulmonary vasculature induces an increased workload on the heart, specifically on 
the right ventricle (RV), which is thin walled compared to the left ventricle (LV). The sustained 
increased resistance of the remodeled pulmonary vasculature resulting from chronic hypoxia causes a 
pressure-overload on the RV and PH. This in turn leads to systolic and diastolic dysfunction, RV 
hypertrophy, dilation, and arrhythmias (Charolidi & Carroll, 2017; Weitzenblum, 2003) (Figure 1.1). 
The described effects on the RV are the major prognostic factors of PH which is a main outcome of 
pulmonary chronic hypoxia (McLaughlin et al., 2004). Pulmonary disorders can systemically manifest 
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themselves, particularly in cardiac function. PH, which is itself a manifestation of lung disease is the 
cause of 10-30% of HF admissions in the USA, highlighting the importance in assessing the effects of 
non-cardiac diseases on heart function (Han, McLaughlin, Criner, & Martinez, 2007).  
1.2 Atherosclerosis  
The two main forms of cardiovascular disease that contribute most to mortality rates are MI and stroke, 
both of which atherosclerosis is the underlying factor. Development of atherosclerosis is a chronic 
inflammatory process, characterized by arterial stiffening, narrowing and eventual build-up of plaque. 
The initial formation of atherosclerotic plaque is inherently site-specific to areas of disturbed blood 
flow (VanderLaan, Reardon, & Getz, 2004). Blood has laminar flow in straight arteries where the 
endothelium is exposed to high shear stress. In branching and curving areas of the arterial tree, 
hemodynamic flow is disturbed and causes areas of low shear stress on the endothelium (Caro, 2009). 
These areas of disturbed blood flow cause endothelial dysfunction by altering the barrier function of 
the vascular endothelial cells (Chiu JJ & Chien C, 2011). It is at these localized sites that plaque 
development begins, meaning these are prime sites for plaque detection.  
The formation of an atherosclerotic plaque is a long process beginning with platelet aggregation at 
lesion-prone sites, followed by the inflammatory response. The increased permeability of the 
dysfunctional endothelium and increased expression of adhesion molecules, allows for the extravasation 
and accumulation of lipids, immune cells and other circulating plasma molecules (Massberg et al., 
2002). Throughout disease progression, accumulated lipids within the intima are taken up by 
macrophages creating foam cells, which are a hallmark of advancing atherosclerotic lesions. Increased 
phagocytosis of lipid material causes macrophage apoptosis, which is the basis of formation of a lipid 
rich necrotic core (LRNC) (Falk, 2006). On top of the LRNC lies a thin-cap fibroatheroma (TCFA). 






1.2.1 Vulnerable plaque 
An unstable or vulnerable plaque is the term used for atherosclerotic plaques that are particularly prone 
to rupture. These are characterized by the macrophage-infiltrated TCFA overlying a large LRNC 
(Figure 1.2). In comparison, a stable plaque has an intact thick fibrous layer comprised of smooth 
muscle layers and collagen (Figure 1.2). Calcification is often present in these plaques and a small 
LRNC (Finn, Nakano, Narula, Kolodgie, & Virmani, 2010).  In the past few decades, it has become 
increasingly clear that detecting plaque composition is as important as detecting the level of stenosis in 
the vessel. For example, surgical intervention is considered when the carotid artery (CA) has 
approximately ≥75% stenosis (Naylor et al., 2018). However, symptomatic events have been recorded 
with ≤ 75% of luminal narrowing as a result of vulnerable plaque rupture. In fact, it is generally 
suggested that the composition of the plaque is as important in detecting as stenosis level (Shah, 2003). 
This highlights the importance of detecting vulnerable plaque along with stenosis in patients, in order 




Figure 1.2 Vulnerable vs Stable plaque. Comparison between vulnerable and stable atherosclerotic 
plaques. Vulnerable plaques are characterized with large lipid rich necrotic core (LRNC), an overlying 
thin fibrous cap and increased infiltration of inflammatory cells. (LRNC; lipid rich necrotic core).  
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1.2.2 Stroke   
Stroke is one of the primary manifestations of cardiovascular diseases affecting 15 million people 
annually worldwide with outcomes of paralysis, loss of speech and death (Roth et al., 2017). Stroke is 
classified as a form of brain injury stemming from a vascular cause, including cerebral ischemia, 
intracerebral hemorrhage and subarachnoid hemorrhage. This thesis will particularly focus on ischemic 
stroke. 80% of strokes are induced by ischemia in a region of the brain caused by arterial blockage, 
where 10-20% of such ischemic strokes are associated with atherosclerotic carotid artery disease 
(Fairhead & Rothwell, 2005a).    
1.2.2.1 The carotid artery  
The carotid arteries (CA) are the main blood delivery system to the brain. The carotid bifurcation, which 
divides the common carotid artery (CCA) into the external and internal carotid arteries (ECA, ICA) is 
a common and high-risk area for plaque development due to the disturbed blood flow within the 
bifurcation. The ICA directly supplies blood to the brain while the ECA supplies blood to the facial 
regions. The CA bifurcation is a crucial area for detection of vulnerable plaques and is one of the 
primary regions of interest in stroke intervention such as carotid endarterectomy (CEA). The patient 
selection process for CEA is still under high controversy (Naylor et al., 2018), where guidelines are 
continuously developed to reduce cases of ‘unnecessary’ surgical interventions. It is therefore important 
to employ diagnostic tools that are able to characterize plaque composition to reduce avoidable 
procedures and stroke instances.  
1.3 Imaging cardiovascular disease 
The complexity and multifactorial nature of CVD demands techniques that can address CVD research 
questions on a multiscale level. Continuous development of biological and medical imaging 
technologies has allowed CVD research to progress from ex vivo to in vivo settings, where complex 
processes of disease can be visualized in their natural environments, especially with non-invasive 
technologies. Imaging technologies all hold specific advantages and limitations in imaging CVD. It is 
therefore important to select the appropriate imaging modality, that offers the best solution for 
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answering a particular CVD question. The decision on choosing an imaging modality is highly based 
on the specific cardiovascular application. Imaging devices for humans are generally not suitable for 
imaging mice, therefore specialized devices for pre-clinical or clinical CVD imaging must be carefully 
assessed.  
1.3.1 Preclinical imaging of cardiovascular disease  
Imaging modalities used for cardiovascular research in preclinical models must be carefully tailored 
towards the animal model in question, with this section focusing on murine models in particular. The 
myocardium and vascular structures are the main targets for imaging cardiovascular biology. Cardiac 
imaging in mice, particularly the murine heart, is technically challenging due to the small size and fast 
heart rate (400-600bpm) (Breckenridge, 2013; Phoon & Turnbull, 2016). Several imaging modalities 
are routinely used for murine heart imaging, including ultrasound (US) and magnetic resonance imaging 
(MRI). US is based on the transmission of US pulses and the detection of US reflections from tissue 
structures. It is the most frequently used modality in cardiac research, as it can deal with the spatial and 
temporal resolution requirements needed for murine heart imaging non-invasively. Variations in 
anatomical structures such as hypertrophy and dilation can be captured with US. In addition, Colour 
Doppler US allows for analysis on blood flow direction and velocity. This is useful in detection of 
turbulent blood flow in the heart or increased rate in blood flow due to hypertrophy-related pressure-
overload (Lindsey, Bolli, et al., 2018). However, the majority of murine cardiac US imaging is 2-
dimensional and subject to high user-variability, resulting in differences in data interpretation (Phoon 
& Turnbull, 2016). Recently, advances have been made in cardiac 3D-US imaging, however the 
temporal resolution necessary for real-time murine heart detection is inadequate (Damen et al., 2017). 
MRI is based on the magnetic properties of nuclei within the body and their response to radiofrequency 
waves and magnetic field gradients. Although MRI is well established in clinical heart imaging, it is 
still under development for murine heart imaging. The main challenges which face MRI include the 
small size and fast heartbeat of the murine heart causing motion artefacts and requiring gaiting 
techniques due to the low temporal resolution (Akki, Gupta, & Weiss, 2013). However, myocardial 
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perfusion, blood flow and anatomy are highly established with preclinical cardiac MRI especially with 
the use of contrast agents (Lindsey, Bolli, et al., 2018).  
1.3.2 Clinical imaging of cardiovascular disease 
The diagnosis and appropriate course of intervention in CVD relies on advanced imaging techniques. 
US, MRI and computer tomography (CT) are the most widely used modalities for imaging vascular and 
heart diseases. A goal of many CVD imaging devices is to successfully detect arterial stenosis and 
atherosclerotic plaque, for example in the CA. Intravascular devices such as intravascular US (IVUS) 
or optical coherence tomography (OCT) are excellent modalities in detecting stenosis (IVUS) or 
characterizing plaque composition (OCT) (Yoshimura et al., 2012) (Figure 1.3), however intravascular 
devices are inherently invasive and require surgical procedures, making non-invasive imaging devices 
much more attractive.  
1.3.2.1 Clinical imaging of the carotid artery  
Clinical imaging of the CA has historically been directed towards measuring the stenosis level of the 
CA which is used to guide clinicians in their surgical intervention decisions. However, with the 
increasing realization that detecting plaque composition and hence assessing plaque vulnerability is 
crucial in stratifying the risk of stroke; there is a need for non-invasive carotid imaging modalities that 
can successfully accomplish this. US and Color Doppler US (Figure 1.3) is the gold standard for 
screening patients due to its real-time imaging capabilities, patient bed-side location, non-ionizing 
radiation and relative low-cost (Dave et al., 2018). Although US is excellent in measuring stenosis, it is 
yet to be advanced in characterizing plaque composition. The lipid or calcified content can be estimated 
by assessing the echogenicity of the plaque, however these estimations are often faced with high inter-
user variability (Nyman, Lindqvist, Näslund, & Grönlund, 2018). Clinical MRI on the other hand is 
most often used as a secondary diagnostic measure after initial US screening, as it offers high accuracy, 
high spatial resolution and also provides insight into plaque characteristics such as presence of 
intraplaque hemorrhage and LRNC (Figure 1.3). However, the major pitfall of MRI is its high cost and 
10 
 
time constraints, preventing its establishment as a standard screening method in the clinics (Brinjikji et 
al., 2016).  
 
 
1.3.3 From preclinical to clinical imaging  
The difficulty in finding solutions for many CVDs is the translation from pre-clinical studies to clinical 
studies (Wilson, Jermyn, & Leblond, 2018). Murine models are fundamental for basic research and for 
Figure 1.3 Non-invasive and intravascular clinical carotid artery imaging devices. (A) Contrast 
enhanced MR-angiography (MRA), where the white arrow indicates occlusion. (B) Color Doppler US 
superimposed over US image indicating change in blood flow velocities. (C) OCT intravascular image of 
calcified areas of plaque (white arrows) (D) Corresponding IVUS image to (c) also showing calcified areas 
of plaque in CA (white arrows). (MRA: magnetic resonance angiography, US: ultrasound, OCT: optical 
coherence tomography, CA: carotid artery, IVUS: intravascular ultrasound) Figure 1.3 A-B Adapted from 
Saxena, A. et al 2019. Terms of Use: Images are licensed under a Creative Commons Attribution-
NonCommercial-ShareAlike United States License 4.0. http://creativecommons.org/licenses/by/4.0/. Figure 
1.3 C-D adapted from Yoshimura et al. 2012 
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exploration of biological questions that can be translated into clinical applications (Koo, Hamilton, & 
Williamson, 2006). However, mice and humans are inherently different and translation of results from 
preclinical studies must be strictly regulated. Clinical studies are also invaluable, as they are carried out 
in the target model, humans. In particular for CVD, many risk factors that influence the disease, which 
often stem from human behavior have a large impact on CVD outcome and are difficult to implement 
into animal models.  
 
1.4 Optoacoustic Imaging 
The optoacoustic (OA) effect was discovered in 1880 by Alexander Graham Bell, where it was found 
that light can generate sound (Bell, 1880). Following advances in laser technologies, the OA effect 
began to be utilized in biomedical imaging research. OA imaging is based on the excitation of acoustic 
waves by irradiating tissue with pulsed laser light at certain wavelengths. Biological tissues contain a 
variety of chromophores (light-absorbing molecules) that have wavelength-dependent absorption 
coefficients. The absorption of light by the chromophore causes a small pressure increase followed by 
relaxation, which results in the emission of detectable acoustic waves (Figure 1.4A). OA imaging is 
generally split into two broad areas, OA microscopy and OA tomography (OAT). For imaging 
cardiovascular dynamics such as the murine heart or cardiovascular structures of large depths such as 
the human carotid artery, OAT is the most the suitable technique, due to its superior penetration depth 
and imaging speed (X. L. Deán-Ben, Gottschalk, Mc Larney, Shoham, & Razansky, 2017),  
Unlike common optical imaging modalities, OAT is inherently insensitive to scattering of light by tissue 
and can therefore achieve depth penetration in the millimeter to centimeter ranges (Ntziachristos & 
Razansky, 2010). The obtained OA signal, and thus formed OA image, mostly depends on the target 
tissue properties, particularly the optical absorption coefficient. The OA image contrast arises from the 
amount of light absorbed by local chromophores rather than changes in the acoustic impedance (Beard, 
2011). This is particularly powerful in biomedical imaging due to the vast variety of available 
endogenous chromophores including hemoglobin, lipids, water and collagen (Figure 1.4 B). The pulsed 
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laser light employed in OAT is non-ionizing and has no toxic effect on tissue. The non-invasive nature 
of OAT along with the optically derived endogenous contrast and US imaging depths makes it a highly 
attractive system for preclinical and clinical imaging.  
 
1.4.1 Cardiovascular optoacoustic imaging  
OAT is particularly well suited to cardiovascular imaging due to differing absorption coefficients of 
deoxygenated haemoglobin (Hb) and oxygenated haemoglobin (HbO), allowing for in vivo 
discrimination of oxygenation levels in the intact vasculature system. Due to the strong optical 
absorbance of hemoglobin, a vast portion of biomedical research in OA imaging targets 
microvasculature dynamics, for example, neovascularization of tumors (Ron, Deán-Ben, Gottschalk, & 
Razansky, 2019) or hemodynamic changes in the brain in response to stimuli (Gottschalk et al., 2019). 
However, applying OAT for direct cardiovascular imaging applications, such as the murine heart or the 
carotid artery, has its own specific challenges.  
 
 
Figure 1.4 Optoacoustic effect and optical absorption coefficients. (A) Schematic of the optoacoustic 
effect, where light is absorbed by chromophores causing thermal expansion which emits acoustic waves. (B) 
Absorption spectra of biological tissue. (OA; optoacoustic, HbO2; oxygenated haemoglobin, Hb; 
deoxygenated haemoglobin)  
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Cardiovascular OAT is typically carried out in the near-infrared (NIR) optical window, which ranges 
between 660-1300nm (Beard, 2011). Imaging using NIR wavelengths, as opposed to imaging in the 
visible range (380-730nm), allows for deeper penetration of light into the tissue, which is required to 
image deeper structures. Several clinically relevant chromophores for cardiovascular biology, such as 
Hb, HBO and lipids, have their peak absorption within the NIR window.  
The cardiovascular system is dynamic under the influence of the beating heart, hence requiring a system 
with enough temporal resolution that can capture real-time information. However, the fundamental 
parameters required for cardiovascular imaging are not a case of ‘one-size fits all’. Cardiovascular OAT 
requirements for murine models vary considerably compared to imaging humans. It is thus important 
to understand the technical adaptations required in OAT to obtain optimal pre-clinical and clinical 
images.  
1.4.1.1 Pre-clinical cardiovascular optoacoustic imaging 
OAT has been implemented in a number of preclinical mouse studies for cardiovascular applications. 
Yet, the small size and rapid heartbeat of the mouse is a challenge in OAT. Examples of cardiovascular 
OAT studies have included imaging of the abdominal and thoracic aortas in atherosclerotic ApoE-/-  
murine models, whereby gold nanoprobes were used to target specific characteristics of vulnerable 
plaques (Rouleau et al., 2013; C. Wu, Zhang, Li, Li, & Wang, 2016). However, studies were limited to 
ex vivo imaging analysis or cross-sectional 2D images that could only capture a small portion of the 
abdominal aorta.  
Imaging of the intact murine heart has been achieved with OAT, initially captured with multispectral 
optoacoustic tomography (MSOT) with 2D cross-sectional views, targeting sites of myocardial 
infarction using the P and L selectin targeting probes at 10Hz frame rates (Taruttis et al., 2013). 
However, 10Hz imaging of the murine heart results in loss of information as it is an insufficient 
temporal resolution. Volumetric real-time OA imaging of the murine heart has since been achieved with 
a frame rate of 50Hz (Xosé Luís Deán-Ben, Ford, & Razansky, 2015). Functional parameters were 
extracted by beat to beat analysis, such as the pulmonary transit time (PTT), which is the time taken for 
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blood to pass through the pulmonary circuit by measuring the time the blood is ejected from the RV 
and returned to the LV. In order to track blood flow, indocyanine green (ICG) was injected 
intravenously which binds to the serum blood protein, albumin, and can thus be tracked through the 
entire cycle of a single heartbeat. ICG is inherently a fluorescent NIR dye, with peak optical absorption 
at 800nm and is therefore an optimal contrast agent for imaging blood flow dynamics with OA, while 
still obtaining endogenous contrast for anatomical information. The PTT was further assessed by Lin et 
al, using the permanent occlusion surgical MI model (Lin et al., 2017). PTT values were assessed at 
different stages post MI, using 50Hz frame rate and ICG intravenous injection. A decrease in PTT 
values was detected for the longer time points (21 days vs 3 days) post MI. The obtained PTT values 
had a positive correlation with infarct size (Figure 1.5 A). In addition, the PTT values were corroborated 
with LV ejection fraction (LVEF) values obtained with MRI, where PTT and LVEF had an inverse 
correlation (Figure 1.5 B) meaning that the lower the PTT values the higher the LVEF, which is 
indicative of increased LV function (Lin et al., 2017).  
 
1.4.1.2 Clinical cardiovascular optoacoustic imaging 
In recent years, OAT has begun to transition from pre-clinical animal research towards a focus on 
clinical applications. For this to successfully occur, the OAT system must include technical parameters 
Figure 1.5 Pulmonary transit time (PTT) (A) PTT plotted against infarct size (extracted from histological 
measurements), showing a positive correlation. (B) PTT plotted against ejection fraction (measured from 
MRI) showing an inverse correlation. (PTT, pulmonary transit time; MRI; magnetic resonance imaging) 
Adapted with permission from Lin et al. (2017).  
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that are geared towards human imaging. OAT has been implemented successfully in the clinics for 
several applications including detection of Crohn’s disease (Knieling, 2017), dermatological 
pathologies (Chuah et al., 2019) and breast cancer detection (Heijblom et al., 2016; Oraevsky et al., 
2018). It has also been demonstrated in studies primarily focusing on atherosclerosis detection. 
Vulnerable plaques have been detected in rabbit models of CAD with OA intravascular devices (B. 
Wang et al., 2012) and several ex vivo studies on human samples have also demonstrated vulnerable 
plaque detection by utilizing the peak optical absorption of lipids at 1200nm (Allen, Hall, Dhillon, 
Owen, & Beard, 2012; Kruizinga et al., 2014) and matrix metalloproteinase activity in vulnerable 
plaques in ex vivo CAs (Razansky et al., 2012). However, these studies are limited in proper clinical 
translation due to the invasive nature of intravascular methods and ex vivo limitations.  Non-invasive 
OAT attempts have been shown in peripheral arteries of the foot in healthy volunteers, showing clear 
detection between veins and arteries and their real-time pulsing motion (Taruttis et al., 2016). In 
addition, imaging of the CA in a healthy volunteer has been shown with OAT (Dima & Ntziachristos, 
2012), however limited to 2D cross-sectional views. There has been a large focus recently on detecting 
the CA with OAT as it is an attractive region of interest (ROI), laying relatively superficial below the 
skin with depths of mm-cm range. More importantly, the CA is clinically attractive due to the tendency 
of plaque development around the bifurcation site, which could subsequently lead to stroke.  
1.4.2 Optoacoustic imaging setup 
There are numerous OAT setups, usually geared towards a specific application of interest. Figure 1.6 
illustrates a schematic of a general OAT setup. Initial OAT setups only provided 2D cross-sectional 
images, similar to conventional US imaging. However cross-sectional imaging of complex biological 
tissue structures is challenging, since one can only visualize a single 2D plane at a time and acquisition 
of larger volumes rather than a single slice decreases temporal resolution considerably (X. L. Deán-Ben 
et al., 2017). Volumetric or 3D OAT addresses this limitation. In particular, the development of 4D-
OAT2 enables imaging of large volumes, such as whole murine hearts and brains, within a single frame 
 
2
 3D in combination with real-time imaging. 
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and little scanning time (Xosé Luís Deán-Ben et al., 2015; Gottschalk, Fehm, Deán-Ben, Tsytsarev, & 
Razansky, 2016). Although the introduction of 3D and 4D OAT has allowed for a large increase in 
variety of applications to be explored with OA, the design and development of 3D probes and their 
associated instrumentation must still be carefully tailored towards preclinical or clinical applications. 
In order to achieve this, careful coordination and design of the OA imaging set up is necessary to 
establish a successful and functional multidisciplinary OAT setup.  
1.4.2.1 Ultrasound transducer requirements 
The US transducer used in every OAT system detects the acoustic wave generated by the OA effect. It 
is usually composed of piezoelectric elements forming the active surface of the transducer, which detect 
pressure changes and convert them to an electrical signal. A high number of elements increases imaging 
sensitivity, however detection sensitivity scales with element size, therefore element numbers and size 
need to be carefully selected (Beard, 2011). 
 
 3D image acquisition is dependent on the shape of the transducer. Curved linear arrays are common in 
OAT setups, they however are limited to cross-sectional 2D imaging. 3D images can be obtained by 
the transformation of the transducer surface array from a linear to hemi-spherical shape (Schellenberg 
Figure 1.6 Schematic of OAT imaging setup.  
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& Hunt, 2018; Upputuri & Pramanik, 2016). The tightly packed elements arranged on the spherical 
surface detect OA signals from multiple positions and angles around a central focal point, thus forming 
a volumetric image (X. Luís Deán-Ben & Razansky, 2013).    
A single hemispherical transducer design cannot be ideal for a variety of applications, especially when 
balancing the requirements of pre-clinical and clinical cardiovascular imaging. Mice and humans 
possess very different size scales and differences in their physiologies. It is possible to obtain an OA 
image of the whole murine heart or brain in a single frame with a fixed transducer (X. L. Deán-Ben et 
al., 2017),  while in humans the same transducer would most likely not be able to capture an entire 
organ and would benefit more with a handheld approach. In order to account for differences between 
mice and humans, the transducer geometry is crucial. By changing the diameter of the transducer or the 
radial distance between the transducer and the center of the sphere (central focal point), which in turn 
effects the angular coverage of the transducer of the ROI, a variety of imaging parameters can be 
achieved. For pre-clinical imaging of the murine heart, employing a hemispherical transducer of a size 
that can hold the mouse on top would be ideal. Therefore, the angular coverage should be high with 
sufficient penetration depth to capture the heart. However, this particular geometry would be suboptimal 
for human imaging. To successfully image humans with OAT, a hand-held and easy-to-maneuver 
device would maximize coverage across the body, therefore transducer size should be minimized. The 
transducer must also possess mm-cm scale imaging depths to account for anatomical variations and 
deep structures, such as the CA.  
Another parameter that must be addressed in transducer design and optimization is the acoustic 
coupling. For murine heart imaging the transducer is stationary and therefore containing the coupling 
medium is simple. However, for clinical imaging, containing the coupling medium is important for two 
reasons: 1) It must be fully contained due to the handheld nature of the transducer and 2) the holder 
itself must be suitable for imaging humans, i.e. a design that can easily and safely move across the skin. 
In addition to containing the coupling medium, a holder must be designed so that the focal center of the 




1.4.2.2 Laser requirements 
Light delivery to the target tissue is essential in OAT and like transducer design, laser requirements 
vary across different applications. The typical laser used in OAT employs short nanosecond laser pulses 
tunable between visible and NIR wavelengths, typically achieved with optical parametric oscillators 
(OPOs). In addition, the per pulse energy is critical for OAT in order to image at mm-cm depths. 
Nanosecond pulses with energies between 5-100 mJ are required to penetrate tissue and generate 
sufficient OA signal. The safety recommendations dictated by the ANSI limits are used as a guideline 
for maximum energy allowed per square centimeter of imaged tissue (ANSI, 2007). Another important 
laser parameter is the repetition rate of the laser, i.e. laser shots per second, which can range between 
few hertz and several kilohertz. Ideally, a single laser source would be used which can provide all the 
required parameters. However, such a laser would be very complex, large and costly (Stylogiannis et 
al., 2018). Therefore, different lasers are usually assigned to specific application needs. For example, 
imaging fast processes such as the heartbeat or brain activity in mice requires high temporal resolutions 
to account for the rapid biological processes and obtain meaningful data. On the other hand, when 
imaging at a human scale, such as the CA, the pulsing motion of the artery is at a much slower rhythm 
than the murine heart, hence temporal resolution requirements are not as demanding. However, the 
structure of the CA requires deeper light penetration to be detected, which is achieved by imaging at 
higher per-pulse energies and thus requiring a laser capable of 10-100 mJ per pulse. Particularly for CA 
OAT, a tunable laser switchable between 800-1200nm would allow for CA detection and lipid detection 
at 1200nm if imaging atherosclerotic patients.   
Another important consideration in the OAT setup is light delivery from the laser to the tissue. Several 
approaches have been used in a variety of OAT setups (Schellenberg & Hunt, 2018; Xia & Wang, 
2014). For example, the light delivery bundle or fiber bundle, could be placed separately from the 
transducer so that light is directed on one side and OA signal detected from the other side (or nearby) 
by the transducer. Another effective method is the combination of transducer and fiber bundle in the 
same location, so that light delivery and signal detection are simultaneous. In OAT, a fiber bundle 
usually consists of multiple single fibers tightly packed into a bundle, therefore maximizing light 
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delivery. A single fiber bundle is often used, however multiple fiber bundles can be used to maximize 
the illuminated area of the ROI, allowing for increased permissible per-pulse energies and hence better 
imaging depth, effective field of view and signal to noise ratio (Schellenberg & Hunt, 2018; Xia & 
Wang, 2014)  
1.4.2.3 Image acquisition and processing 
The OA effect combines two physical processes; acoustics and optics, both of which have to be 
accounted for when acquiring the OA image. The two most frequently used algorithms for OAT 
reconstruction include filtered back-projection (BP) and model-based (MB). MB offers a more accurate 
reconstruction, however compared to BP is highly computationally expensive(X. Luís Deán-Ben, Ma, 
Razansky, & Ntziachristos, 2011; K. Wang et al., 2013). Biological tissue is heterogeneous causing 
variability in its acoustic properties. Accurate estimation of tissue acoustic properties, such as speed of 
sound, which varies between 1400-1600m/s, can have a large improvement on image quality 
(Lutzweiler & Razansky, 2013). Another reconstruction challenge are limited view artefacts, which are 
obtained from incomplete signal detection of the ROI, especially in hemispherical OAT transducers as 
the elements do not completely surround the object (Yao & Jiang, 2011). However, several approaches 
have been developed to improve limited view artefacts, recently including deep learning methods 
(Davoudi, Deán-Ben, & Razansky, 2019; Yao & Jiang, 2011).    
The optical properties must also be accounted for in OA image processing. The OA signal is a product 
of the optical absorption coefficient and light fluence; the amount of light at a given volume. OA 
contrast arises from the amount of absorbed light of the tissue chromophore and as light penetration in 
tissue is limited due to scattering of photons, the deeper the ROI the less OA signal is detected. 
However, the obtained OA signal corresponds to the tissue chemical composition thus providing 
accurate information of the molecular composition of the tissue. Imaging at different wavelengths, i.e. 
multispectral imaging allows the composition of the tissue to be differentiated into specific molecular 
components, while estimating the concentration of the molecule within the imaged region (Lutzweiler 
& Razansky, 2013; H. F. Zhang, Maslov, & Wang, 2008).   
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1.5 Aims of the thesis  
To gain further insights into CVD, advanced cardiac imaging tools are needed to investigate rapid 
cardiovascular dynamics, in vivo and non-invasively. The murine heart and the human carotid artery 
are fundamentally different. The murine heart is small, superficial from the skin surface and has a rapid 
heartbeat, which requires an extremely high temporal resolution to capture in real-time. The anatomy 
of the human carotid artery varies considerably among individuals, especially the depth and the 
diameter. In order to capture the carotid bifurcation and account for the anatomical variations, it is 
essential to have high-energy lasers for deeper penetration of light and a scannable probe in order to 
locate the ROI. To address the differences in imaging requirements, the thesis aims to explore and 
optimise technical imaging parameters for implementation of OAT for the following cardiovascular 
applications: 
 
Aim 1: Ultra-fast volumetric optoacoustic tomography for monitoring of post-ischemic myocardial 
remodelling of murine models of myocardial infarction. (Chapter 2) 
Aim 2: Volumetric optoacoustic tomography of impaired heart function under hypoxic conditions. 
(Chapter 3) 
Aim 3: Volumetric optoacoustic tomography of the human carotid artery visualised in a multispectral, 
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Myocardial healing following myocardial infarction (MI) is a complex process that is yet to be fully 
understood. Clinical attempts in regeneration of the injured myocardium using cardiac stem cells faced 
major challenges, calling for a better understanding of the processes involved at a more basic level in 
order to foster translation. We examined the feasibility of volumetric optoacoustic tomography (VOT) 
in studying healing of the myocardium in different models of MI, including permanent occlusion (PO) 
of the left coronary artery, temporary occlusion (ischemia-reperfusion - I/R), as well as infarcted c-kit 
mutants, a genetic mouse model with impaired cardiac healing. Murine hearts were imaged at 100Hz 
frame rate using 800nm excitation wavelength, corresponding to the peak absorption of indocyanine 
green (ICG) in plasma and the isobestic point of haemoglobin. The non-invasive real-time volumetric 
imaging capabilities of VOT have allowed the detection of significant variations in the pulmonary 
transit time (PTT), a parameter affected by MI, across different murine models. Upon intravenous 
injection of ICG, we were able to track alterations in cardiac perfusion in I/R models, which were absent 
in wild-type (wt) PO or kitW/kitW-v PO mice. The wt-PO and I/R models further exhibited irregularities 
in their cardiac cycles. Clear differences in the PTT, ICG perfusion and cardiac cycle patterns were 
identified between the different models and days post MI. Overall, the results highlight the unique 
capacity of VOT for multi-parametric characterization of morphological and functional changes in 








Ischemia of the myocardium is the most common type of myocardial injury characterised by a 
prolonged period of reduced blood flow to the heart muscle (Tanai & Frantz, 2011). Ischemic damage 
of the heart induces a process of cardiac remodelling, by which extensive morphological, histological 
and molecular changes occur both within the necrotic and healthy myocardium (St. John Sutton & 
Sharpe, 2000). Until recently, the mammalian heart was assumed to lack regeneration capabilities due 
to the incapacity in of cardiomyocytes to proliferate (Kazu & Poss, 2012). Recent studies have shown 
that resident cardiac stem cells positive for the stem cell factor c-kit, possess regenerative properties 
and can promote the healing response of the myocardium following myocardial infarction (MI) 
(Urbanek et al., 2005). These observations have fostered preclinical research and clinical studies on 
stem cell therapies for post-infarct myocardial healing (Behfar, Crespo-Diaz, Terzic, & Gersh, 2014; 
Bergmann et al., 2009; Madigan & Atoui, 2018). However, while initial clinical trials yielded promising 
results, these were not substantiated by larger trials involving different types of cell therapies. This 
called for a better understanding of the fundamental processes involved in cardiac healing post MI and 
how pluripotent cells effect the healing response. Efforts are therefore being redirected towards 
improving the preclinical settings in terms of MI models and providing methodological advances to 
enable more effective in vivo observations (Tompkins et al., 2018).  
Arguably, longitudinal in vivo imaging represents the most promising approach for assessing dynamic 
changes in morphology, function and molecular biology during the healing phase post MI. The existing 
technologies, such as positron emission tomography and magnetic resonance imaging (MRI) (Yu, Qian, 
Chen, Dodd, & Koretsky, 2014), lack key performance metrics required for imaging rapid dynamics in 
the whole mouse heart, and only regular heartbeat can be observed via prospective or retrospective 
gaiting (Lindsey, Kassiri, Virag, Castro Bras, & Scherrer-Crosbie, 2018). Ultrasound (US) provides a 
cost-effective and non-invasive approach for imaging of the murine heart in real time. US has been 
shown to be capable of resolving anatomical changes in response to MI. However, standard 2D cross-
sectional US images are prone to artefacts related to cardiac motion and inter-user variability. (Provost 
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et al., 2014). While there has been significant development in increasing temporal resolution of 3D US, 
gaiting techniques are still required for murine cardiac imaging (Damen et al., 2017). 
Recently, volumetric optoacoustic tomography (VOT) has been suggested as a novel imaging tool for 
in vivo murine heart analysis capable of capturing the entire 3D volume of the beating mouse heart non-
invasively and in real-time (Xosé Luís Deán-Ben et al., 2015; Lin et al., 2017). Beat-to-beat analysis of 
healthy and infarcted murine heart models enabling quantification of functional parameters, such as the 
pulmonary transit time (PTT), defined as the time it takes for blood to pass through the pulmonary 
circuit connecting the two ventricles (Ivankovic et al., 2019; Lin et al., 2017). The PTT is estimated by 
tracking the bolus of a blood pool dye (indocyanine green – ICG) following intravenous (IV) injection 
(Xosé Luís Deán-Ben et al., 2015). The PTT was found to increase in MI models while an inverse 
relationship between PTT and time post MI surgery was further observed. (Lin et al., 2017). Herein, we 
employed VOT for assessing myocardial function in vivo in different MI models, in order to assess the 
feasibility of VOT to detect functional changes of the myocardium across different murine models of 
MI. We hypothesize that VOT is able to capture distinct differences in myocardial function post MI 
induced via permanent occlusion (PO) or ischemia-reperfusion (I/R) as well as infarcted c-kit deficient 
(kitW/kitW-v) mice, a genetic mouse model with impaired cardiac healing which has been frequently used 




2.3 Materials and methods 
 
2.3.1 Acute murine MI models: permanent occlusion, reperfusion, c-kit deficiency  
All animal procedures and their care were conducted in conformity with national and international 
guidelines (EU 2010/63) with approval from the local authority (Government of Upper Bavaria) and 
supervised by the Animal Care and Use Committee of Klinikum Rechts der Isar, Munich and the 
Helmholtz Center Munich. Animals were housed in standard animal rooms (12 h light/dark cycle, 50-
60% humidity, 18-23°C temperature, bedding material) in individually ventilated cage systems (IVS 
Techniplast) under specific pathogen-free conditions with free access to water and standard laboratory 
chow ad libitum. Female wild-type albino C57Bl/6J mice (wt) (n = 26) and WBB6F1-KitW/KitW–v 
mice (kitW/kitW-v) (n=13) aged 12-14 weeks were used as MI models (Figure. 2.1A). All mice were 
intubated and mechanically ventilated for MI surgery after removal of hair from their chest. The 
intervention was performed by a veterinarian experienced in small animal surgeries. The rib cage was 
exposed between the 4th and 5th rib. MI induction was based on ligation of the left anterior descending 
coronary artery (LAD) (Wildgruber et al., 2014). In the wt -PO model (n=13), MI induction involved 
consistent closure of the LAD using 8 sutures (Figure 2.1A, left panel). The wt-I/R model (n=8) 
involved temporary occlusion of the LAD for approximately 30 minutes followed by reperfusion 
(Figure. 2.1A, middle panel). kitW/kitW-v mice lack the tyrosine receptor kinase c-kit, which is essential 
for proliferation, survival and migration of cardiac stem cells (Di Siena et al., 2016). MI was induced 
via PO in kitW/kitW-v models (kitW/kitW-v PO) (n = 13) (Figure 2.1A, right panel). In all MI models, the rib 
cage was bound with three stiches and the skin was subsequently closed with transparent surgical glue. 
Control or non-infarct mice for wt models (n=9) and kitW/kitW-v (n=5) underwent no surgery. VOT 
imaging was as performed at 3 (3d), 10 (10d) and 21 (21d) days post-surgery (MI) for wt-PO (3d, n=3; 
10d, n=6, 21d, n=4) and kitW/kitW-v PO (3d, n=4; 10d, n =5; 21d, n=3) models, while I/R injury was 










2.3.2 VOT imaging setup 
A detailed description of the VOT imaging set-up is provided elsewhere (Lin et al., 2017). In short, the 
imaging system consists of a 512-element hemispherical array transducer (custom-made Imasonic SaS, 
Voray, France) with a central US frequency of 5 MHz and ~100% detection bandwidth 
(Figure 2.1B). The VOT images rendered with this array have an almost isotropic resolution of 150 µm 
within an effective field of view (FOV) of approximately 10x10x10 mm3. OA signal excitation was 
achieved by illuminating the mice with a tuneable (700-900 nm) pulsed (<10 ns) near-infrared laser 
(Innolas Laser GmbH, Krailing, Germany) via an optical fibre bundle (Ceram Optec GmbH, Bonn 
Germany) through a central cavity in the transducer array. In the experiments, the wavelength was tuned 
to 800 nm (peak absorption of ICG in plasma) and the laser was operated at 100 Hz with maximum per-
Figure 2.1: Schematic of experimental procedure. (a) Procedure of MI induction for varying models with 
surgical technique and MI outcome. The black cross indicates the suture, the grey shading on left ventricle 
indicates infarct area and 30 minutes indicates length of occlusion of LAD (MI; myocardial infarction, 
LADAD; left anterioranterior descending artery, PO; permanent occlusion, I/R; ischemic reperfusion, RI; 
reperfusion injury) (b) Simplified diagram of ultrasound transducer with fibre output for light delivery to 
murine heart and curved array for detection of optoacoustic signals. (c) 3D rendered volumes of optoacoustic 




pulse energy of 20 mJ. All 512 OA signals detected by the array elements were simultaneously sampled 
at 40 Megasamples per second by a custom-made data acquisition system (Falkenstein Mikrosysteme 
GmbH, Taufkirchen, Germany). 3D volumes of 12x12x12 mm³ (120x120x120voxels) were 
reconstructed for each laser pulse using the filtered back projection algorithm (Dean-Ben, Ozbek, & 
Razansky, 2013) without employing signal averaging (Figure 2.1C). For this, the raw signals were 
band-pass filtered between 0.1-7 MHz and deconvolved with the impulse response of the transducer 
elements. For better visualization, a median filter with kernel size 3x3x3 was applied to the 
reconstructed images. The graphics processing unit (GPU) implementation of the algorithm further 
enabled real-time preview during the experiments. All processing steps and analyses were performed 
in Matlab (version 9.1, R106; MathWorks) and Amira (Zuse Institute, Berlin, Germany) was used for 
image visualization. 
2.3.3 In vivo imaging procedures 
For imaging with the VOT imaging set-up, mice were anesthetised with a 2% isoflurane-medical air 
mixture (0.8 l/min gas flow). Hair on the chest surrounding the imaged heart region was shaved to 
minimise image artefacts associated to light and sound attenuation. Mice were then placed in prone 
position on top of a solid agar block (1.3% w/v) filling the volume enclosed by the spherical array 
pointing upwards. Optimal acoustic coupling for ultrasound transmission was further guaranteed by 
adding a layer of ultrasound gel between the agar and the skin. The mouse heart was placed into the 
centre of field of view with the help of real-time image preview (Dean-Ben et al., 2013). Subsequently, 
IV injection of 100 nmol indocyanine green (ICG, Profiplus Bvba, Korstessem, Belgium) diluted in 
50 µl of saline solution was performed and the PTT was measured by tracking the ICG bolus perfusion 
through the heart with VOT (Xosé Luís Deán-Ben et al., 2015). A total of 5000 volumetric image frames 
were acquired over 50 sec at a wavelength of 800 nm (peak absorbance of ICG) with the injection 
performed 15 sec after beginning the acquisition. Mice were reinjected with the same ICG concentration 
10 minutes after the first acquisition. Imaging of each mouse lasted for about 30 minutes. The 
physiological parameters of the animal were constantly monitored throughout the experiments 
(PhysioSuite, Kent Scientific, Torrington, Connecticut).  
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2.3.4 PTT in response to varying MI models 
The PTT was measured for all models and compared between the different groups. The automated 
method to extract the PTT has been described previously (Lin et al., 2017). In short, tracking the ICG 
bolus perfusing through the heart was done by tracking the OA signal intensity variations at different 
points. The PTT was estimated as the difference between the time points corresponding to maximum 
signal intensities at the right and left ventricles. The value obtained (in seconds) corresponds to the time 
it takes for the ICG bolus (blood) to complete the pulmonary circuit. All PTT values for each MI model 
(wt and kitW/kitW-v) were initially compared to non-infarct mice (wt and kitW/kitW-v) and then plotted on 
different days post infarct in order to identify presence of a positive myocardium remodelling. 
2.3.5 In vivo analysis of reperfusion injury 
Analysis of reperfusion injury in wt-I/R models was carried out post image reconstruction. Areas 
located in the region where the LAD was temporary occluded were thoroughly analysed in the VOT 
images for suspected damage. The hearts of wt-I/R models were compared to wt-PO models and non-
infarcted mice to identify presence of the reperfusion injury, which should be absent in the surgical PO 
and non-infarcted mice. Perfusion of ICG through the heart and its interaction with the suspected 
reperfusion injury was further assessed on a beat-to-beat basis for both I/R and PO models. Endothelial 
dysfunction is a known outcome of reperfusion injury, where the vasculature in the injured area may 
become leaky. Therefore, the dynamics of the OA signal intensity was measured at the different stages 
of ICG perfusion to examine whether albumin-bound ICG extravasates due to increased vascular 
permeability at sites of reperfusion injury. 
For validation of increased microvascular permeability for ICG, cryosections containing IV injected 
ICG obtained 24 hours after I/R, were further stained for CD31 (ab28364, Abcam) and detected with 
an Alexa 647-coupled secondary antibody (Jackson 111-605-144). Mounting media containing DAPI 
(Thermo Scientific) was used for tissue embedding and visualization of the cell nuclei. All slices were 
imaged using an Eclipse 50i microscope (Nikon) and NIS-Elements BS 3.22 software (Nikon). 
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Cryosections were H&E stained according to standard protocols and imaged using an Axio Imager 
M2 microscope (Carl Zeiss) equipped with Zeiss Zen pro 2.0 software (Carl Zeiss). 
2.3.6 Cardiac cycle characterization 
The high temporal resolution of the VOT system enabled analysis of heart activity on a beat-to-beat 
basis. Irregularities within the cardiac cycle were detected using the interactive viewer View4D 
(Matlab), where the cardiac cycle could be clearly visualised in the OA signal intensity time profiles. 
The cardiac cycles in the recorded 5000 volumetric image frames were analysed for all models and time 
points post MI. 
2.3.7 Statistical Analysis  
Statistical analysis was carried out on measurements taken from wt-PO, wt-I/R and kitW/kitW-v PO and 
non-infarct models. Boxplots of PTT values were plotted for all MI models and non-infarct models and 
subsequently compared with each other with a one-way analysis of variance (ANOVA). ANOVA was 
carried out for assessing differences in heart regeneration of the different models at time points (3, 10 
and 21 days) post MI followed by Tukey’s post hoc test for multiple comparisons. The result of the 
ANOVA rejects the null hypothesis at 5% significance level, i.e., p values less than 0.05 were 
considered to show statistical significance.   
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2.4 Results  
 
2.4.1 PTT varies across different MI models 
PTT values for different mouse models were estimated via ICG injection as described in the methods 
section. The PTTs of the wt-PO were significantly longer compared to non-infarct mice (Figure 2.2A, 
p<0.0001). The highest PTT values were observed 3 days post MI and subsequently decreased over 
time indicating healing of the injured myocardium and functional improvements over 21 days. As the 
ANOVA analysis indicated significant difference in the PTTs at different days post MI, Tukey post hoc 
tests were performed. Post hoc comparisons using the Tukey HSD test indicated that the PTT in mice 
at 10 days post MI were significantly different from 3 and 21 days post MI (M= 2.2720, SD=0.1878, 
p=0.0017).  For the wt-I/R model, which induces a less severe infarct, longer PTTs were also observed 
compared to the non-infarct mice (Figure 2.2B, p=0.0206). However, the decrease in PTT values from 
day 3 to day 21 post MI showed no statistically significant difference over time (p=0.2828).  
PTT values of the kitW/kitW-v group were analysed to assess effects of the c-kit protein deficiency on 
heart function and remodelling post MI. kitW/kitW-v after PO were compared with non-infarcted kitW/kitW-
v mice in addition with wt-PO to assess effects of c-kit expression on the functional healing response in 
MI by VOT. The effect of the deficiency of the c-kit protein on heart function was assessed from VOT 
measurements of kitW/kitW-v mice at 3, 10 and 21 days post MI surgery. No improvement in the PTT was 
measured in kitW/kitW-v mice after PO with respect to non-infarct kitW/kitW-v (Fig. 3, p<0.0001). In 
contrast to what was observed in wt mice (Fig. 2a), ventricular function did not recover in kitW/kitW-v PO 
mice. VOT-derived PTT values following MI showed no significant differences at different days (3, 10 
and 21) post MI (Fig. 3, p = 0.7079). These results imply that the lack of proper healing and impaired 





Figure 2.2: Pulmonary transit times in PO and I/R models. (a) PTT values represented no MI (blue) and 
3, 10 and 21 days post MI for wt-PO (red) models. ANOVA analysis showed statistical significance for 
different days (p < 0.0001), suggesting myocardial healing. (PTT; pulmonary transit time, PO; permanent 
occlusion, MI; myocardial infarction). (b) PTT values represented in boxplots for no MI (blue) and I/R 
models (orange), where the PTT was statistically shorter in no MI mice compared to I/R models (p = 0.03) 
and PTT values represented at 3 and 21 days post MI showed no statistical difference (p = 0.28) suggesting 





2.4.2 VOT detects ICG perfusion through reperfusion area   
Reperfusion injury is a pathophysiology associated with rapid blood reperfusion following 
recanalization of an occluded coronary artery during MI treatment. wt-I/R mice showed disrupted 
vasculature located in regions affected by the temporary LAD ligation (Figure 2.1C, white arrows). 
Similar vasculature was not detected in PO models (wt and kitW/kitW-v mice). The presence of injuries in 
wt-I/R models was corroborated by assessing the ICG perfusion through the suspected injury sites and 
compared to the PO and non-infarct mice (Figure 2.4A). ICG (bound to blood plasma) clearly perfused 
through structures located on top of the heart (white arrows in Figure 2.4A), as manifested by an 
increase in the OA signal intensity at these points (Figure 2.4B). No signal increase was detected in the 
Figure 2.3: Pulmonary transit times in kitW/kitW-v models. PTT values represented with no MI (blue) and 
3, 10 and 21 days post MI (purple). ANOVA analysis showed significant difference in PTT values between 
no MI and MI models (p<0.0001) and no significant difference in PTT values was detected for 3, 10 and 21 










Figure 2.4: Reperfusion injury detection (a) ICG perfusion tracking in I/R (3 & 21 days), PO and no MI models, 
where before (yellow), early (orange) and late (red) ICG phases are shown. Note white arrows identifying areas 
where ICG either perfused through (both I/R models) and where ICG didn’t perfuse through (PO & no MI). Each 
column of OA MIP images represent coronal views (left) and sagittal views (right). (ICG; indocyanine green, I/R; 
ischemic reperfusion, PO; permanent occlusion, MI; myocardial infarction). (b) OA signal time intensity plotted 
at reperfusion injury sites or similar locations are shown for each model over a period of 1000 frames, where 
different phases of ICG perfusion are depicted (before - yellow, early - orange, late - red). OA images in (A) 
correspond to the colored bars in the OA signal time intensity plots. Note how there is a clear increase in OA 
signal in I/R models and no OA signal change in PO and control models. (OA; optoacoustic) (c) Fluorescence 
microscopy of infarcted myocardium 24h following I/R shows a gradient of ICG (red) across the microvascular 
endothelium (*, CD31 staining in green) into the perivascular space. H&E staining of infarcted myocardium at 




PO and non-infarct mice, suggesting that the observed absorbing structures do not correspond to 
disrupted vasculature. On the other hand, the increased VOT signal intensity was maintained for a 
relatively long time for the selected structures in the wt-I/R models, which appears to indicate the 
presence of leaky vasculature. See supplementary video 1 for visualisation of ICG perfusion through 
the I/R heart. Altered ICG leakage due to increased endothelial permeability was confirmed using 
fluorescence microscopy (Fig. 4C). Within the infarcted myocardium, ICG (red) was shown to 
distribute along a gradient across the microvascular endothelium (green*) into the perivascular space, 
corroborating the in vivo OA detected ICG signal in reperfusion models. 
2.4.3 VOT detects arrhythmic cardiac dynamic variations between PO and I/R mice 
Cardiac cycles were examined with VOT in the wt-PO, wt-I/R mice as well as in kitW/kitW-v mice after 
PO MI. An example of 5000 volumetric OA image frames recorded over 50s is available in 
Supplementary video 2. Irregularities in the cardiac cycle (arrhythmias) were associated to elongated 
cycles with 82 ±31% increase in duration as compared to standard (periodic) cycles (Figure 2.5A). In 
periodic cycles (yellow shade), ventricular activity remained relatively consistent, while ventricular 
activity was concentrated in diastole in the irregular cycles (Figure 2.5A, red shade), occupying 
approximately 75% of the cycle length. Cardiac cycle irregularities were detected in all wt-PO mice 
(n=21) and in 37.5% of wt-I/R mice (3 out of 8 mice, n=8), while only periodic cycles were detected in 
kitW/kitW-v PO mice (n=12) (Figure 2.5B). Longer PTTs were also found in wt-I/R mice featuring cardiac 
cycle irregularities but not in mice with regular cardiac cycles (Figure 2.5C, p<0.01). Thus suggests a 
high correlation between PTT values and the presence of arrhythmic events, as also observed in hypoxic 









Figure 2.5: Cardiac cycle characterization in MI models. (a) OA signal intensity time profile plotted in 
grey curve where periodic cycles are detected in the beginning followed by irregularity. Above time plot are 
individual OA frames of the beating heart across 600 ms, where yellow shading represents a periodic cycle 
and red shading represents and irregular cycle. Note the differences in systolic and diastolic phases. (OA; 
optoacoustic, RA; right atrium, LA; left atrium, RV; right ventricle, LV; left ventricle). (b) Histogram showing 
occurrence of cycle irregularities in PO, I/R and kitW/kitW-v models, where 0% occurrence was noted in c-kit 
models, 37.5% occurrence in I/R models and 100% occurrence in PO models. Orange color represents 
irregular cycles and green represents regular cycles. (PO; permanent occlusion, I/R; ischemic reperfusion) (c) 
Boxplot representation of relationship between PTT values and cardiac cycle trends in I/R models, where a 
longer PTT was found in models with cycle irregularities (n=3) compared to models with regular cardiac 
cycles (n=5) (p = 0.005)  
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2.5 Discussion  
 
The presented results illustrate the advantages of VOT in assessing cardiac dynamics following 
myocardial infarction. Various models of MI are available to help deepen our understanding of the 
healing response in response to mechanically or genetically-induced ischemic injuries. The goal of this 
study was to assess whether VOT can capture distinct yet subtle differences in myocardial injury 
following MI. The unique capacity of the VOT technique for the simultaneous assessment of cardiac 
morphology, function, rhythm and vascular morphology in vivo and in real time has the potential to 
offer new insights into the biology of myocardial healing and remodelling.  
The PO model involves consistent closure of the LAD, which mimics a clinical acute, untreated MI 
with relatively large infarct size and worse prognosis (Lindsey, Bolli, et al., 2018; Muthuramu, Lox, 
Jacobs, & De Geest, 2014). Ligation of the LAD for 30 minutes in wt-I/R models resembles the clinical 
scenario of coronary revascularization by undergoing rapid treatment in acute MI (Lindsey, Bolli, et al., 
2018). The different surgical techniques employed in this study which have imposed varying 
mechanical stress levels to the heart, have also resulted in different healing routes post MI. Herein, it 
was shown that PTT values vary amongst different MI models. In PO models, the PTT was generally 
longer than in the wt-I/R models agreeing with the high severity of the induced injury. The PTT has 
previously been shown to vary depending upon the time point post MI and its size (Lin et al., 2017). 
The PTT and left ventricular ejection fraction (LVEF) have also been shown to inversely correlate, 
suggesting that ventricular function can be determined by analysing the PTT. In addition, PTT 
measurements enabled the assessment of cardio-pulmonary interactions and function under stress 
(Ivankovic et al., 2019). In general, longer PTT values indicate impaired heart function. The 
normalization of PTT values in the PO model indicate myocardium healing following MI, while no 
significant changes in PTT values were detected in the I/R model. In support of these findings, no 
change or improvement in LVEF was detected in patients with reperfused MI and subsequent 
reperfusion injury (Ganame et al., 2009). Therefore, although it is generally accepted that I/R models 
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impose less severe infarcts compared to PO models, it appears that the healing capacity in I/R models 
is hindered, which possibly reflects the impact of reperfusion injury.  
The regenerative capabilities of c-kit cells in the heart has long been debated. Experimental results have 
shown that c-kit cells do indeed promote heart regeneration post MI, which have prompted clinical trials 
yielding controversial outcomes (Hsieh et al., 2007; Yu et al., 2014). The inconclusive results call for 
more preclinical investigations before translating treatment strategies into the clinical setting. For this, 
advanced imaging techniques with sufficient spatio-temporal resolution for studying the murine heart 
can be of great value. VOT is capable of capturing the murine heart in real-time, non-invasively and 
volumetrically, posing as an ideal imaging device to image cardiovascular disease in preclinical models. 
We tested the sensitivity of VOT by examining different murine MI models. In the kitW/kitW-v mice, no 
relevant regeneration of cardiac function was detected by VOT over a 21-day period post permanent 
LAD ligation. These findings were compared to PO in wild-type mice under identical experimental 
conditions, where an improvement in LV function was recorded. This highlights VOT’s capacity to 
assess different degrees of the healing response to MI and emphasizes the important role of c-kit cells 
in cardiac regeneration post MI (Hsieh et al., 2007).  
The acquired data of the wt-I/R model were further investigated to assess the presence of impaired 
vasculature with increased endothelial permeability, common in reperfusion injuries. The VOT images 
of the wt-I/R hearts presented morphological differences compared to mice without reperfusion injury 
(PO and infarct). Notably, increased leakage of ICG into extravascular space was identified around the 
infarct area, where reperfusion injury is expected to occur (Granger & Kvietys, 2017). I/R is known to 
cause endothelial dysfunction through various mechanisms, where permeability of the endothelium 
increases following I/R, thus perpetuating myocardial injury (Granger & Kvietys, 2017). Albumin, 
which ICG binds to in vivo when IV injected, has been previously shown to be a bio-marker of vascular 
permeability as its structure (like other large serum proteins) tend to accumulate in areas of increased 
vascular permeability (Vandoorne, Addadi, & Neeman, 2010). The increased VOT-detected leakage of 
albumin-bound ICG following IV injection, may thus serve as a bio-marker of endothelial dysfunction 
in wt-I/R models (Alander et al., 2012). These observations were only recorded in wt-I/R models and 
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were not present in wild-type and kitW/kitW-v mice following PO. The ICG retention in the injured region, 
as confirmed by fluorescence microscopy, of the I/R hearts similarly follow a previously described 
schematic on ICG perfusion in MI models (Sonin et al., 2017; Vandoorne et al., 2010). Different phases 
of ICG perfusion post MI were studied in an I/R rat model. It was shown that in the initial (arterial) 
phase of perfusion, ICG fills the coronary arterial network of the heart including vasculature with 
restored blood flow. It was also shown that this is followed by the delayed (capillary) phase, where ICG 
is detected only in regions of myocardial injury. Disrupted coronary microcirculation was also observed 
in areas of irreversible reperfusion injury, where excessive leakage of plasma was present (Sonin et al., 
2017). Compared to the unaffected myocardium, the excessive leakage causes retention of ICG, 
resulting in an OA signal increase measured by VOT. In this study, the entire perfusion cycle of ICG 
and its retention in the reperfused areas of the myocardium could be detected in real-time and non-
invasively. This allowed for fast and direct detection of areas subject to irreversible damage from I/R 
MI and could serve as a diagnostic tool in classifying the severity of the cardiac injury in those models.  
High-frame-rate (100 Hz) imaging with VOT has further allowed for a beat-to-beat analysis of the 
cardiac cycles. Rapid detection of cycle irregularities was possible due to the true 4D imaging 
capabilities of VOT, whereby volumetric images of the heart and the OA signal intensity time profiles 
at different points could simultaneously be analysed. All PO-induced mice presented at least one 
instance of cycle irregularity in the cardiac cycle post MI, while in wt-I/R models irregularities were 
detected only in 3 out of 8 mice. Notably, no irregularities were observed in the kitW/kitW-v mice. Cardiac 
arrhythmias are common in patients following MI, where cycle irregularity can be attributed to slower 
or faster heart rates (Cohen, Boiangiu, & Abidi, 2010; Tung & Zimetbaum, 2010). The irregular cycles 
detected by VOT exhibited almost double the length of the regular periodic cycles, where ventricular 
activity was extended in the diastolic phase; potentially representing arrhythmic events. The real-time 
heart motion of the heart is known to serve as an important indicator for the MI assessment (Thygesen 
et al., 2012). The obtained results suggest that severity of the MI models (with PO considered as the 
most severe) may dictate frequency of the detected arrhythmic events. However, it remains unclear why 
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no arrhythmic events were detected in the kitW/kitW-v mice, and future studies are anticipated to elucidate 
these findings.  
In conclusion, we have shown that dedicated preclinical cardiac VOT imaging can serve as an advanced 
imaging tool for assessing myocardial injury and function in different MI murine models. VOT is 
capable of rendering real-time, volumetric and non-invasive data of the murine heart, thus allowing for 
a comprehensive analysis of the whole heart function under MI stress. Thereby, it has the potential to 
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Exposure to chronic hypoxia results in pulmonary hypertension characterized by increased vascular 
resistance and pulmonary vascular remodelling, changes in functional parameters of the pulmonary 
vasculature, and right ventricular hypertrophy, which can eventually lead to right heart failure. The 
underlying mechanisms of hypoxia-induced pulmonary hypertension have still not been fully elucidated 
while no curative treatment is currently available. Commonly employed pre-clinical analytic methods 
are largely limited to invasive studies interfering with cardiac tissue or otherwise ex vivo functional 
studies and histopathology. In this work, we suggest volumetric optoacoustic tomography (VOT) for 
non-invasive assessment of heart function in response to chronic hypoxia. Mice exposed for 3 
consecutive weeks to normoxia or chronic hypoxia were imaged in vivo with heart perfusion tracked by 
VOT using indocyanide green contrast agent at high temporal (100 Hz) and spatial (200 µm) resolutions 
in 3D. Unequivocal difference in the pulmonary transit time was revealed between the hypoxic and 
normoxic conditions concomitant with the presence of pulmonary vascular remodelling within hypoxic 
models. Furthermore, a beat-to-beat analysis of the volumetric image data enabled identifying and 
characterizing arrhythmic events in mice exposed to chronic hypoxia. The newly introduced non-
invasive methodology for analysis of impaired pulmonary vasculature and heart functions under chronic 
hypoxic exposure provides important inputs into development of early diagnosis and treatment 





3.2 Introduction  
Pulmonary hypertension (PH) is a disorder characterized by pulmonary vascular remodelling, right 
ventricular hypertrophy and increased pulmonary arterial pressure. PH has been associated with various 
disorders while, according to the recent WHO classification, it is regarded as a separate entity when 
associated with hypoxia or chronic diseases of the respiratory system (Heresi et al., 2017). The latter 
include chronic obstructive pulmonary disease (COPD), interstitial lung diseases, sleep disordered 
breathing, but also chronic exposure to high altitude and some rare neonatal diseases (Forfia et al., 2013; 
Stenmark et al., 2006).  
Murine models have been widely used to gain deeper insight into lung-heart interactions under chronic 
hypoxic conditions (E. Cahill et al., 2012). The hypoxia-inducible factor (HIF) has been highly 
implicated in the development of PH (Shimoda & Semenza, 2011) where several preclinical studies 
focus on the molecular mechanisms of HIF and its role in PH (Chen, Shen, Zhang, & Shu, 2017; Li et 
al., 2016; L. Wang, Zhou, Li, & Zhu, 2014; Yamashita et al., 2008). However, there is a lack of direct 
functional studies of the heart in response to chronic hypoxia. Methods for assessing pulmonary and 
cardiac structural alterations in PH are usually limited to histopathological ex vivo analyses looking at 
right ventricular (RV) hypertrophy and pulmonary vasculature changes. RV catheterization is an 
invasive in vivo procedure to measure pressure differences as a surrogate parameter of increased 
pulmonary arterial pressure (Campen, Shimoda, & O’Donnell, 2005; Fagan, 2001; Howell, Preston, & 
McLoughlin, 2003; McGuire & Bradford, 1999). Yet, the majority of the analytical methods interfere 
with integrity of the heart, which calls for introduction of new methods for direct in vivo assessment of 
cardiopulmonary coupling in small animal models. 
In vivo imaging of the murine heart is challenging due to its small size and rapid motion (Doevendans, 
Daemen, De Muinck, & Smits, 1998), which imposes hard requirements on the spatial and temporal 
resolution of non-invasive imaging modalities to accurately capture a heart volume of less than a cubic 
centimeter beating at a 400-600 cardiac cycles per minute. Even though cardio-respiratory gating in 
magnetic resonance imaging (MRI) and X-ray computed tomography (CT) may enable characterizing 
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some of the in vivo functional cardiac parameters, those methods are generally ill-suited for cardiac 
imaging due to insufficient temporal resolution when performing true 3D whole-heart imaging at high 
spatial resolution (Kojonazarov et al., 2018; Yu et al., 2014). To this end, ultrasound (US), and more 
recently ultrafast US, are arguably the most suitable modalities for cardiac imaging in murine models. 
US enables discerning anatomy and measuring important physiological parameters, such as blood flow 
(Pistner et al., 2010). Yet, it is generally not suitable for measuring some of the key functional 
parameters in the entire heart volume in 3D, in particular for analysis of right ventricular size within 
murine models. To our knowledge, very few methods generally exist for non- or minimally-invasive 
imaging and assessment of the effects of exposure to chronic hypoxia in pre-clinical models. 
Optoacoustic (OA) imaging is becoming an increasingly powerful tool in pre-clinical research, in 
particular for in vivo cardiac imaging in murine models, for a number of reasons: (1) the high number 
of effective voxels rendered by state-of-the-art systems allows for imaging the whole murine heart with 
high spatial resolution using stationary matrix detection arrays; (2) optical contrast allows for blood 
perfusion monitoring (Xosé Luís Deán-Ben et al., 2015), and (3) the high temporal resolution in 3D 
facilitates analyzing functional parameters of the living murine heart on a beat to beat basis (Lin et al., 
2017). An important functional parameter that can be measured with OA via injection of a contrast 
agent is the pulmonary transit time (PTT). The latter has been shown to significantly decrease in infarct 
murine models and hence can serve as an important indicator of heart function (Lin et al., 2017). 
Another key feature of volumetric optoacoustic tomography (VOT) is the ability of imaging the entire 
heart with a single laser pulse. This is crucial to characterize potential delays in cardiac activation across 
different regions, e.g. during arrhythmic events. In this work, we demonstrate the capabilities of a 
recently developed real-time three-dimensional OA imaging system for analyzing heart function in vivo 




3.3 Materials and methods 
3.3.1 Animal models  
All animal procedures were approved by the local legislation on protection of animals (Government of 
Upper Bavaria, Munich, Germany under animal protocol reference number 55.2-1-2532-50-12) and 
conducted in accordance with the European directive 86/609/EEC and internal regulations of the 
Technical University of Munich and Helmholtz Centre Munich. Mice (129S/Sv/C57BL6 mixed 
background) were maintained for 21 days either under normoxic conditions (n=3) or under hypoxic 
conditions (10% oxygen, n=4) in a custom-built normobaric chamber, as described previously 
(Chalupsky, Kračun, Kanchev, Bertram, & Görlach, 2015).  
3.3.2 Animal handling 
All mice were anesthetized with approximately 2% isoflurane – oxygen medical mix (~0.81 L/min gas 
flow) for in vivo imaging of the heart. The fur covering the region of interest was initially clipped and 
then completely removed with hair removal cream. During imaging, the anesthetized mice were placed 
on top of a solid agar matrix filling the volume enclosed by the spherical array (Figure 3.1 A). Warmed 
ultrasound gel was further used between the tissue surface and the agar matrix for optimum acoustic 
coupling and maintaining homeostasis. Approximately 15 sec after beginning of the image acquisition 
each mouse was intravenously injected with 100 nmol/L of indocyanine green (ICG) contrast agent 
(Profiplus Bvba, Kortessem, Belgium) diluted in 50 µl saline solution. Mice were then injected a second 
time 10 minutes after the first injection.  
3.3.3 Volumetric optoacoustic tomography (VOT) of the murine heart  
High-frame-rate images of the beating murine heart were acquired with a VOT system specifically 
designed for high performance pre-clinical cardiac imaging (Figure 3.1 B) (Dean-Ben et al., 2013; Xosé 
Luís Deán-Ben et al., 2015). The imaging system consists of a spherical array transducer (Imasonic Sas, 
Voray, France) composed of 512 piezoelectric elements with 5 MHz central frequency and >80% 


















The large angular coverage of the array reduces limited-view effects and further enables an improved 
sensitivity and deeper penetration. In the experiments, the spherical array was held pointing upwards 
(Figure 3.1 A). The spherical volume enclosed by the spherical aperture was filled with clear agar 
(3w/v% concentration), which provided acoustic coupling while being transparent for light. Short light 
pulses (<10 ns) at 800 nm wavelength and 100 Hz repetition frequency were generated by a fast-tuning 
optical parameter oscillator laser (Innolas Laser GmbH, Krailling, Germany) and guided via a fibre 
bundle (Ceram Optec GmbH, Bonn, Germany) through the center of the transducer array. The 800nm 
wavelength corresponds to the absorbance peak of ICG. The OA signals for all elements of the array 
were simultaneously sampled by a custom-made parallel data acquisition system (Falkenstein 
Figure 3.1: The experimental protocol (A) Non-invasive imaging procedure of the murine heart with the 
volumetric optoacoustic tomography. (OA; optoacoustic, ICG; indocyanine green, NIR; near-infrared, PC; 
personal computer, GPU; graphics processing unit, DAQ; data acquisition system). (B) 3D view of the 
optoacoustic image a of the murine heart reconstructed with a single laser pulse (AA - aortic arch, RA - 
right atrium, LA - left atrium, RV - right ventricle, LV - left ventricle). (C) Temporal profiles of the 
optoacoustic signal intensities in two voxels in RV and LV, as indicated in (B). (D) The pulmonary transit 
time (PTT) is calculated as difference in time of arrival of the contrast agent, i.e. time difference 
corresponding to the maximum signal values in the RV and LV (Hx; mean-1.91 [1.7386 – 2.02] s versus 
Nx; mean-1.43 [1.0602-1.64] s, P < 0.0023). [Add copyright info here, do this for all images.] 
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Microsysteme GmbH, Taufkirchen, Germany). Volumetric images were reconstructed on the fly for 
each laser pulse by a graphics processing unit-based 3D back-projection reconstruction algorithm, 
which enabled real-time preview during the experiments and facilitated correct positioning of the 
animal (Ozbek, Dean-Ben, & Razansky, 2013). After correct positioning, VOT data was acquired for a 
total of 5000 frames and 3D images were later reconstructed offline in a volume of 12x12x12 mm3 
(120x120x120 voxels). All processing steps were performed in MATLAB (MathWorks Inc, Natick, 
USA). 
3.3.4 Pulmonary transit time (PTT) 
The method for extracting the PTT values from the heart image sequence has been previously described 
(Xosé Luís Deán-Ben et al., 2015). In short, the PTT was measured as the difference between the time 
points corresponding to the maximum signal peaks for the right (RV) and left ventricles (LV), 
corresponding to the time of appearance of the ICG bolus (Figure 3.1 C). The PTT was measured for 
both hypoxic and normoxic models, followed by statistical analyses. Voxels in the RV and LV were 
identified in the VOT images using a 4-dimensional viewing toolbox in Matlab. 
 
3.3.5 Cardiac cycle characterization 
OA signal intensity profiles were extracted from different locations in the LV and RV, the left atria and 
right atria as well as the aortic arch by selection of voxels in the images. These cycles were used for 
characterizing the heart rate as well as irregularities corresponding to arrhythmias. The latter were 
identified when the length of a single cycle significantly exceeded the average cycle length of a normal 
periodic rhythm. Also, the spectrogram of the cardiac cycle was calculated as the short-time Fourier 
transform (STFT) of the signals. The STFT was used to resolve the frequency content at specific time 
points and track it over time. Abnormal beating events are expected to result in a lower frequency 




3.3.6 Immunohistochemistry and Fulton index  
Hypoxia-induced pulmonary vascular remodelling was validated by immunohistochemistry, as 
described previously (Chalupsky et al., 2015). Briefly, lung tissue samples were immersed in 10% 
buffered formalin solution for 48 h and subsequently embedded in paraffin (FFPE). FFPE lung sections 
were stained with an antibody against α-smooth muscle actin (clone 1A4; DAKO, Hamburg, Germany). 
The slides were heated at 60°C for 1 h before rehydration in a series of alcohol solutions of decreasing 
alcohol concentration. The endogenous peroxidase activity was quenched in 1% hydrogen peroxide 
solution in methanol. The hydration process was completed by rinsing in DAKO wash buffer. Sections 
were heated in a water bath at 90°C while submerged in antigen retrieval pH 9 epitope retrieval solution 
(DAKO) for 30 min. They were subsequently blocked in blocking reagent for 1 h, and then incubated 
with the antibody 1:100 diluted in M*O*M diluent (Vector M*O*M kit) (Vector Laboratories, 
Burlingame, CA) for 1 h at room temperature in a humidity chamber. The sections were washed in 
DAKO wash buffer and the secondary antibody was applied (anti-mouse IgG in dilution 1:250). The 
avidin–biotin complex (Vectastatin Elite Kit, Vector Laboratories) was applied to the slides for 30 min 
at room temperature. The chromogenic reaction was performed with diaminobenzidine (DAB; DAKO) 
for 5 min at room temperature. Slides were counterstained with Mayer's hematoxylin for 30 s (Merck, 
Darmstadt, Germany), dehydrated in an ascending alcohol concentration, and mounted with Entelan 
(Merck). Positive and negative controls were included with each run. For evaluation of each lung, small 
α-smooth muscle actin positive vessels less than 30µm were identified in three randomly selected 
regions of interest covering an area of 1mm² each (Z. Zhang et al., 2019).  
To determine the Fulton index as a measure of right ventricular hypertrophy, the right ventricle was 





3.4.1 Volumetric optoacoustic tomography of the murine heart:  
The VOT imaging setup was optimally designed for in vivo murine heart imaging (Figure 3.1A). The 
dedicated design consists of a spherical array transducer which was held pointing upwards for optimal 
OA signal detection of the heart, a fiber bundle for light illumination, a fast-tuning optical parameter 
oscillator laser and a data acquisition system for simultaneous OA signal detection for all elements of 
the array. Mice which have been exposed to chronic hypoxia for 3 weeks (n=4) and normoxic 
counterparts (n=3) were anesthetized and laid on the transducer with the chest facing down. High-
frame-rate images of the beating murine heart were acquired with the VOT system, specifically 
designed for high performance pre-clinical cardiac imaging (Figure 3.1 B). The VOT data was acquired 
for each ICG injection for a total duration of 50 s (5000 frames), which is a sufficient amount of time 
to track blood flow through the pulmonary circuit. 
3.4.2 Pulmonary Transit Time  
The PTT was measured as the difference between the time points corresponding to the maximum signal 
peaks for the right (RV) and left ventricles (LV), corresponding to the time of appearance of the ICG 
bolus (Figure 3.1C). Boxplots of the measured PTT values for hypoxia-treated (n=4 , 6 injections 
altogether) and normoxic models (n=3 , 6 injections altogether) are presented in Figure 3.1D. A t-test 
was carried out to analyze the difference between the observed PTT values. The PTT values measured 
from the hypoxic models were significantly longer than those obtained for the normoxic models (mean-
1.91 [1.7386 – 2.02] s versus mean-1.43 [1.0602-1.64] s, P < 0.0023). This clear difference in PTT 
between hypoxia-treated and normoxic mice strongly suggests that chronic hypoxia affects cardiac 






3.4.3 Immunohistochemistry and right ventricular hypertrophy 
Characteristically, exposure to chronic hypoxia results in a vasoconstrictor response as well as in 
muscularization of small pulmonary vessels indicative of pulmonary vascular remodelling leading to 
an increase in pulmonary vascular resistance and right ventricular hypertrophy. As evinced by staining 
for α-smooth muscle actin of lung sections (Figure 3.2A), the number of small muscularized pulmonary 
vessels was significantly increased in lung sections from hypoxic mice in comparison to normoxic mice 
(Figure 3.2B), indicating pulmonary vascular remodelling. Subsequently, the masses of the right and 
left ventricle including septum were measured and the Fulton index was determined as a measure of 
right ventricular hypertrophy. Compared to the normoxic mice, the Fulton index was elevated in 
hypoxic mice indicating right ventricular hypertrophy (Figure 3.2C) 
3.4.4 Heart beat characterization 
Due to the excellent temporal resolution of the VOT system, it was possible to characterize the heart 
motion on a beat-by-beat basis. Heart rate variability was clearly identified within the hypoxic models 
(n=3 (3 of 4)) in VOT image sequences of 500 frames (100 frames per second), whereas only periodic 
cycles were recorded in normoxic models (Figure 3.3A). A t-test analysis revealed that the irregular 
cycles, marked with grey crosses in Figure 3.3A, have a length of 333 [282 – 437.3] ms versus 189 [145 
– 229] ms, P < 0.001 (Figure 3.3B). The real-time 3D imaging capability of VOT allows for mapping 
the mechanical motion globally throughout the heart by plotting time-lapse OA signal intensity profiles 
in different locations within the heart wall (Figure 3.3C). The profiles indicate that the length of the 
irregular heart cycle is approximately twice the duration of the regular cycles. This may be attributed 
to a steady sinus rate and impaired atrioventricular conduction or ‘heart block’ rather than a supra-
ventricular arrhythmia (Goldberger, 2017). Atrial deformations may additionally be produced during 
ventricular pauses, which may become visible if the resolution of the VOT system is enhanced by using 




The cycle length lasts for approximately 430 ms, by which ventricular activity is primarily in diastole 
(D). The irregular cycles are also clearly visible in the supplementary videos of the reconstructed VOT 
image sequences available in the on-line version of the journal. Figure 3.3D shows the short-time 
Fourier transform (STFT) analysis carried out on image data from a hypoxia-treated murine model 
revealing multiple irregularities throughout cycle length. By calculating the frequency spectra of the 
time profiles as a function of time, the STFT facilitates detecting changes of heart rate over time, 
corresponding to arrhythmic events as areas of lower frequencies of the time-series (Figure 3.3D). The 
green arrows in Figure 3.3D represent irregular cycles, while the white dashed lines indicate breathing 
periods. The profile in Figure 3.3D show that the peaks of normal contractions before and after 
Figure 3.2: Staining for α-smooth-muscle actin of murine lungs. Formalin fixed and paraffin embedded 
(FFPE) lung sections derived from normoxic (Nx) or hypoxic (Hx) mice were stained for α-smooth-muscle 
actin and the number of muscularized small vessels (<30 µm) was counted. (A) Small muscularized vessels 
are indicated with arrows. (B) Graph shows the number of small muscularized vessels per mm2 lung tissue, 
assembled from three regions of interest per lung (n=3, **p<0.01 Hx vs. Nx). (C) The Fulton index as 
measure of right ventricular hypertrophy was determined as ratio between mass of the right (RV) and left 
ventricle (LV) with septum (S) (n=3, *p<0.05 Hx vs. Nx). 
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arrhythmic events follow a defined periodicity, which further suggests failure in atrio-ventricular 
conductivity. 
  
Figure 3.3: Optoacoustic characterization of impaired heart function in hypoxic models. (A) Examples of 
time-lapse optoacoustic signal intensity profiles for selected voxels in the heart of normoxic and hypoxic mice 
(n=4). Irregular heart beating events are marked with grey crosses in the time traces for hypoxic models.  (B) 
Boxplots of the measured cycle period for normal versus abnormal beating cycles (NB - normal beating, AB - 
abnormal beating). (C) Volumetric mapping of the heart mechanical motion and onsets of the irregular beats, 
where the colored circles in the heart in systolic phase (S – blue box) correspond to the colored OA signal 
profiles below. The red shade in the profiles indicate heartbeat onset at varying locations and the yellow shade 
indicates the duration of the heartbeat. The diastolic phase of the heart (D-red panel) is the heart phase present 
for the majority of the heartbeat (RA – right atrium, LA, left atrium, RV – right ventricle, LV – left ventricle, 
S-systole, D-diastole). (D) Short-time Fourier transform (STFT) of the temporal OA signal profile in a selected 
voxel in hypoxic heart, where blue indicates normal beating periods and red indicates irregular beating periods. 
Green arrows identify the areas of abnormal beat periods in the time series and the areas of low frequency 




3.5 Discussion  
Pre-clinical animal models are commonly used to investigate the pathophysiology of pulmonary 
hypertension and potential therapeutic interventions. Exposure to chronic hypoxia over 3 weeks 
characteristically leads to pulmonary hypertension in mice. To this end, pre-clinical assessment of PH 
has been largely limited to ex vivo or invasive procedures that interfere with the integrity of the heart 
tissue, hampering an accurate assessment of heart function within an intact living organism. 
Development of new imaging approaches is thus crucial for comprehensive understanding of the scope 
of PH in an in vivo environment.  
In this study, we have examined the potential of VOT for assessing in vivo heart function in murine 
models of chronic-hypoxia-induced PH. The high temporal resolution of the imaging system enables 
tracking fast perfusion of contrast agents and estimation of the pulmonary transit time (PTT), a valuable 
capacity for functional assessment of the heart and pulmonary circuit dynamics. PTT has previously 
been shown to serve as an accurate indicator of heart performance, specifically left ventricular 
performance under pathophysiological conditions in the murine heart (Lin et al., 2017). In this study, 
we have shown that the PTT in murine models exposed to chronic hypoxia was considerably longer 
than in normoxic models. As the PTT is determined by cardiac function and pulmonary hemodynamics, 
these findings point to deteriorated cardio-pulmonary function in response to chronic hypoxic 
conditions. In fact, as indicated in this study, chronic hypoxia results in pulmonary vascular remodelling 
and right ventricular hypertrophy. This has not only been associated with an increase in pulmonary 
vascular resistance and right ventricular pressure due to increased afterload in chronic hypoxic mice 
(Chalupsky et al., 2015; Z. Zhang et al., 2019), but has also been associated with a decreased ability of 
conductance vessels to store and deliver the entire stroke volume of the right ventricle and ultimately 
resulting in a loss of pulmonary flow during diastole (Stenmark et al., 2006). PTT values (or CPTT - 
Cardiopulmonary Transit Times) have been previously studied in humans by using  the first pass 
radionuclide cardiography technique (Zavorsky, Walley, & Russell, 2006). In support of our studies on 
hypoxia-induced PH in mice, longer PTT values were shown in patients with pulmonary hypertension 
(Skrok et al., 2012; Y. W. Wu et al., 2017). PTT is becoming increasingly recognized as an important 
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marker for cardiopulmonary function, where very recent studies have been evaluating the PTT in 
patients using MRI and US (Monahan et al., 2019). At present, pulmonary hypertension in mice is 
mostly characterized by invasive measurement of right ventricular pressure, and ex vivo 
histopathological analysis of pulmonary and cardiac tissues. Very recently, MRI and US has been 
applied to evaluate pulmonary hypertension in the more severe hypoxia/Sugen5416 murine model by 
measuring right ventricular ejection fraction (Breen, Scadeng, Lai, Murray, & Bigby, 2017) However, 
in mice PTT was only determined invasively using microangiography (Sonobe et al., 2011). VOT 
enables measuring the PTT in vivo in mice, thus offering a new efficient and non-invasive tool to 
monitor heart remodelling and pulmonary circuit dynamics in models of pulmonary hypertension.  
Arrhythmic events, in particular atrial fibrillation or flutter have been frequently observed in patients 
with pulmonary hypertension or COPD (Hanrahan et al., 2008). However, heart rate or arrhythmia have 
not been well documented in the adult chronic hypoxia murine model. Here we show that irregular heart 
cycles were present in mice exposed to chronic hypoxia as detected in the time profiles of the VOT data 
that represented mechanical motion of the heart in three dimensions. Although actual blood pressure 
values cannot be extracted from the VOT data, the non-invasively recorded OA signal intensity changes 
extracted at given spatial locations, plotted similar patterns to pressure waveforms usually extracted via 
catheterization (Kern, Donohue, Bach, & Aguirre, 1992). This is expected considering that pressure 
changes in the heart chambers induce a displacement or strain in the heart walls, which are easily 
detectable in the OA signal intensity profiles. In catheterization procedures, pressure waveforms can 
only be measured at a specific location of the heart, which generally hinders measuring the delays 
between mechanical activation across different heart regions. With the suggested VOT approach, the 
OA signal intensity changes can be simultaneously obtained from multiple locations in the heart, which 
enables readily identifying such delays and could serve as an alternative method to strain imaging which 
also maps mechanical activation across the heart. The preliminary results presented here on cycle 
variability have promoted future studies on this topic using VOT in order to fully understand the effect 




In conclusion, in vivo simultaneous detection of two impaired heart functions have been demonstrated 
with VOT in the murine model of chronic-hypoxia-induced pulmonary hypertension. The PTT and 
heart rate were both altered in hypoxic hearts compared to normoxic hearts. Overall, VOT has been 
suggested as a method offering new capabilities for in vivo volumetric beat-by-beat characterization of 
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4.1 Summary Statement: 
This study investigates whether volumetric multi-spectral optoacoustic tomography (vMSOT) can 
provide three-dimensional assessment of anatomical and functional status of the entire bifurcation area 
of the human carotid artery non-invasively and in real time. 
 
4.2 Implications for patient care: 
The study suggests the future potential of using OA imaging for the diagnosis of carotid artery diseases, 
e.g. for characterizing vulnerable plaques in humans. 
The non-invasive nature of optoacoustics further indicates its applicability as a screening platform in 






Multispectral optical imaging has the capability of resolving hemoglobin, lipid, and water. Volumetric 
multispectral optoacoustic tomography (MSOT) is a hybrid imaging technique that provides a unique 
combination of functional and molecular contrast with real-time handheld imaging. The aim was to 
investigate whether volumetric MSOT can provide real-time assessment of the anatomic and functional 
status of the human carotid artery bifurcation noninvasively. Imaging of healthy volunteers (n = 16) 
was performed with a custom-designed handheld volumetric MSOT scanner capable of high-spatial-
resolution (approximately 200 μm) and real-time (10 volumes/sec) three-dimensional imaging, 
while further providing spectroscopic capacity through fast tuning of the excitation light wavelength. 
For comparison and anatomic cross-validation, volunteers were also scanned with clinical B-mode US. 
Volumetric MSOT achieved real-time imaging and characterization of the entire carotid bifurcation 
area across three dimensions simultaneously captured in a single volumetric image frame. Analysis of 
the acquired data further showed that a higher 
contrast-to-noise ratio can be achieved for wavelengths corresponding to a high optical absorption of 
oxygenated hemoglobin. The human carotid artery was visualized by using handheld volumetric 
multispectral optoacoustic tomography. This imaging approach is less prone to motion artefacts than 
are the conventional clinical imaging methods, holding promise for providing additional image-based 




4.4 Introduction  
Most ischemic strokes are associated with carotid artery disease originating from the bifurcation area 
(Fairhead & Rothwell, 2005b; Mughal et al., 2011). Methods for visualizing human carotids include 
duplex US (Jahromi, Cinà, Liu, & Clase, 2005), CT (Josephson et al., 2004), and MRI (Cai et al., 2005). 
However, rapid characterization of tissue function and molecular composition is limited with these 
modalities. Recently, intravascular optical imaging approaches assisted with smart fluorescence 
molecular agents have demonstrated powerful performance in detecting specific atherosclerotic 
biomarkers, including inflammation, protease upregulation, lipid content in areas of high endothelial 
permeability, and vascular cell adhesion molecules (Jaffer et al., 2011, 2007; Kaul & Lindner, 2004; 
Vinegoni et al., 2011). Yet fluorescence-based methods can at best provide a qualitative indication of 
the existence of biomarker activity, rather than an accurate assessment of its biodistribution. 
Optoacoustic imaging provides unique opportunities for accurate diagnostics and assessment of carotid 
artery disease. To this end, the technique has been used in diverse angiographic applications and enabled 
multiscale imaging of vascular structures ranging from capillaries to major vessels, including cross-
sectional (two-dimensional) carotid imaging, at depths of several millimeters to centimeters in living 
tissues (X. L. Deán-Ben et al., 2017; Xosé Luís Deán-Ben & Razansky, 2013; Dima & Ntziachristos, 
2012). Multispectral optoacoustic tomography (MSOT) can further provide valuable functional 
information by spectroscopically identifying the presence of specific tissue chromophores and extrinsic 
agents (Mandal, Deán-Ben, Burton, & Razansky, 2015) or evaluation of physiologic conditions with 
label-free mapping of blood oxygen saturation in tissues (Tzoumas et al., 2016). MSOT imaging of 
matrix metalloproteinase activity, typically associated with atherosclerotic plaque instability, has been 
demonstrated in ex vivo human carotid plaque samples (Razansky et al., 2012). By using excitation in 
the wavelength range of 1210 nm, corresponding to the peak optical absorption by lipids, optoacoustic 
imaging could clearly identify and characterize plaques within human aorta and carotid artery samples 
ex vivo (Allen et al., 2012; Kruizinga et al., 2014). 
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The goal of this study was to investigate whether optoacoustic imaging can be used clinically to provide 
three-dimensional assessment of anatomic and functional status of the entire bifurcation area of the 
human carotid artery noninvasively and in real time, thus addressing limitations of the existing imaging 




4.5 Materials and Methods 
 
We devised a handheld volumetric MSOT system to enable noninvasive, real-time, three-dimensional 
visualization of human carotids (Figure 4.1A). It features spherical array detection geometry with nearly 
isotropic three-dimensional resolution of 200 μm (X. Luís Deán-Ben & Razansky, 2013), wide 
tunability of the excitation light in the range of 680–950 nm, and parallel data acquisition for real-time 
imaging at a volumetric frame rate up to 100 Hz. The laser further features a separate output delivering 
the fundamental pumping wavelength of 1064 nm. The detection array was attached to a holder 
containing a liquid acoustic coupling medium (water) sealed with a transparent membrane (Figure 
4.1A). The images were rendered in a volume of 20 × 20 × 20 mm3 (200 × 200 × 200 voxels) and then 
cropped along the depth (or z) axis for better visualization of the carotid artery. Graphics processing 
unit–based implementation of the reconstruction procedure allowed for a live preview of the three-
dimensional optoacoustic images (Dean-Ben et al., 2013). All processing steps were performed in 
Matlab (version 9.1, R2016b; MathWorks, Natick, Mass). Image visualization and analysis were 
performed in Amira (Zuse Institute, Berlin, Germany). 
 
For this preliminary study, no institutional review board approval was required as set out for 
noninterventional human studies by the German Drug or Medical Device Act. Healthy volunteers 
consisting of female and male researchers (age range, 22–44 years) with no history of cardiovascular 
diseases were recruited between April 2017 and November 2018. Written informed consent was 
obtained from all volunteers. Exclusion criteria were physical or mental conditions inhibiting volunteers 
from making informed judgements, history of cardiovascular disease, pregnancy, or breastfeeding. The 
final cohort consisted of 16 healthy volunteers with mean age ± standard deviation of 29.75 years ± 
5.55 (nine of 16 [56.25%] women with mean age of 28 years ± 2.66; seven of 16 [43.75%] men with 
mean age of 32 years ± 7.23). All volunteers consented to be imaged with the handheld volumetric 
MSOT probe in full accordance with the work safety regulations of the Helmholtz Centre Munich 





















The pulse repetition rate of the laser was set to 10 Hz while the maximal light fluence on the skin surface 
was maintained below 20 mJ/cm2 in the range of 730–900 nm and below 50 mJ/cm2 at 1064 nm to 
fulfill the safety exposure limits (ANSIZ136.1, 2014) for nanosecond laser radiation in the entire 
wavelength range used in our experiments. All volunteers were imaged at wavelengths of 850 nm and 
1064 nm for optimal visualization of the carotid artery. Five volunteers (three women [60%] with mean 
age of 26.6 years ± 3.3; two men [40%] with mean age of 40.5 years ± 3.5) were also imaged between 
730–900 nm for multispectral evaluation. The acquired volumetric MSOT images of two volunteers 
(two women with mean age of 28.5 years ± 2.5) were further compared against state-of-the-art clinical 
US (Logiq S8; GE Healthcare, Wisconsin) obtained with 11L linear transducer (GE Healthcare) carried 
out by an experienced vascular surgeon (C.G.S.).  
Figure 4.1: Images show volumetric multispectral optoacoustic tomographic (MSOT) imaging 
setup. A, Diagram illustrates handheld noninvasive scanning procedure, where volumetric MSOT probe 
is scanned on skin surface around carotid artery bifurcation area. B, Three-dimensional view of 
reconstructed volumetric MSOT image of carotid bifurcation captured at video rate of 10 Hz in a 44-
year-old man. CAB = carotid artery bifurcation, CCA = common carotid artery, ECA = external carotid 
artery, FB = fiber bundle, ICA = internal carotid artery, LB = laser beam, STA = superior thyroid artery, 




No unpleasant sensations were reported during or after the imaging sessions. The skin area was also 
carefully examined for any unexpected damage immediately after the sessions. No adverse effects were 
reported within 1 month following the scanning procedures. 
We first examined the general feasibility of identifying the carotid artery bifurcation with the handheld 
volumetric MSOT imaging probe. Figure 4.1B shows a perspective view of the three-dimensional 
tomographic reconstruction of this area acquired at a single wavelength of 850 nm from a healthy 
volunteer. Figure 4.2A shows the coronal and sagittal views color coded with depth, revealing the skin 
surface (red and orange), the closest carotid wall at a depth of 5–7 mm (green), and the deeper wall at 
a depth of 16 mm (blue). The optoacoustic signal is mainly generated by whole blood (haemoglobin) at 
the periphery of the vessel lumen, which allowed for clearly distinguishing the carotid walls (see CW 
in Figure 4.2A). The top maximum intensity projection of the captured image volume is displayed in 
Figure 4.2B, where superficial structures were removed so that the entire anatomy of the carotid 













Figure 4.2: (A, B) Noninvasive volumetric multispectral optoacoustic (OA) tomographic anatomic  
imaging of carotid artery bifurcation in vivo in a 44-year-old man. (A) Image shows depth 
characterization. Maximum intensity projections (MIPs) of volumetric reconstructions along z and y 
directions are color coded to represent depth (in millimeters), where structures in red identify superficial 
contrast and blue and purple are indicative of deeper structures. (B) MIP of volumetric reconstruction of 
carotid bifurcation after removal of contrast arising from shallow structures. Orange box in A indicates 
depth range used for rendering MIP in B. CC = common carotid, CW = carotid wall, EC = external carotid, 
IC = internal carotid, S = skin. 
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We further scanned an extended area spanning 45 mm along the common carotid and bifurcation by 
using illumination wavelength of 1064 nm. The multiple image volumes were subsequently stitched by 
means of a spatial compounding technique (Nitkunanantharajah, Hennersperger, Dean-Ben, Razansky, 
& Navab, 2018) to render the carotid anatomy at a larger scale (Figure 4.3). The scanning procedure 
can be best visualized in Movie E1 (online), showing three-dimensional views of the carotid bifurcation 
along with the common carotid artery, internal carotid artery, and external carotid artery in a single 
imaging session. Figure 4.4 summarizes optoacoustic signal decay against carotid depth in all the 16 
volunteers measured at wavelengths of either 850 nm or 1064 nm. Detectable signals with signal-to-











Anatomic features resolved with the volumetric optoacoustic scans were validated against US images 
recorded from two female volunteers (mean age, 28.5 years) by using the clinical B-mode scanner 
(Figure 4.5). Although the entire carotid bifurcation area could be readily visualized with the volumetric 
MSOT owing to its three-dimensional imaging capabilities, it was not easily discernable in single cross-
sectional US images. For instance, whereas US visualization of the whole carotid bifurcation in a single 
cross-section (Figure 4.5A) required an extended acquisition time to find the suitable orientation of the 
US probe, a similar view could readily be obtained from the three-dimensional optoacoustic image. 
Figure 4.3: Compounded image of handheld volumetric multispectral optoacoustic (OA) tomography 
scan along entire carotid artery in a 26-year-old woman. CC = common carotid, EC = external carotid, 





















Multispectral data were subsequently acquired from five healthy volunteers (three women [60%] with 
mean age of 26.6 years ± 3.3; two men [40%] with mean age of 40.5 years ± 3.5) at wavelengths of 730 
nm, 760 nm, 800 nm, 850 nm, and 900 nm, as shown in Figure 4.6A. Note that the generated 
optoacoustic signal is affected by the wavelength-dependent light attenuation in tissues, which can be 
estimated by considering the hemogblobin absorption spectra (Figure 4.6B) (Xosé Luís Deán-Ben, Bay, 
& Razansky, 2014). From a theoretical standpoint (Jacques, 2013), for average tissue oxygenation 
values below 75%, such effective attenuation is expected to peak at 760 nm while having a local 




Figure 4.4: Graph shows signal-to-noise-ratio (SNR) of optoacoustic signal recorded noninvasively 
from superficial carotid wall and plotted against its depth in 16 volunteers. Measurements were 
performed at wavelength of either 850 nm (seven women [77.7%] with mean age ± standard deviation of 
28.28 years ± 2.05; two men [22.22%] with mean age of 40.5 years ± 3.5) or 1064 nm (four women [50%] 


















It was observed that the attenuation peak at 760 nm results in a local minimum in signal (and 
subsequently in contrast-to-noise ratio) at this wavelength for most volunteers (n = 5), whereas a 
contrast-to-noise ratio peak was observed at 800 nm for some of the volunteers, arguably due to the 
reduced attenuation at this wavelength. It is important to consider that the optoacoustic spectrum of the 
carotid artery is influenced by additional factors such as the depth at which the artery is located and the 
presence of veins or other highly absorbing structures in the surrounding tissue. Indeed, optical 
properties in biologic tissues are generally heterogeneous and difficult to estimate, which hampers 
accurate quantification of sO2 in vascular structures. Overall, images at longer excitation wavelengths 
exhibit higher contrast-to-noise ratios owing to the high oxygen saturation of the arterial blood and the 
Figure 4.5: Images show qualitative comparison of image quality between volumetric multispectral 
optoacoustic tomographic (hereafter, vMSOT) and B-mode US in two volunteers. Right carotid artery 
(RCA) and left carotid artery (LCA) are shown in a 31-year-old woman (subject 1) and in a 26-year-old 
woman (subject 2), respectively. A, vMSOT images of carotid artery bifurcation in coronal view represented 
in maximum intensity projections (MIPs). B, vMSOT and B-mode US images of carotid bifurcation in 
sagittal cross-sectional views. Orange and green frames correspond to vMSOT and US images, respectively, 
where orange dashed lines in A indicate section shown in B. CC = common carotid, EC = external carotid, 
IC = internal carotid, OA = optoacoustic. 
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corresponding trend in the oxygenated hemoglobin absorption spectrum. The measured contrast-to-
noise ratio of the images in the range of 800–900 nm has a mean value of 18.8 dB ± 4.28 while having 
lower values of 9.18 dB ± 3.8 for shorter wavelengths of 730–760 nm (Figure 4.6E). 
  
Figure 4.6: Multispectral and CNR analysis (A) Volumetric multispectral optoacoustic (OA) tomography 
images show right carotid artery bifurcation in a 23-yearold woman taken in wavelength range of 730–900 
nm. (B) Graph shows spectral dependence of optical absorption by oxygenated hemoglobin (HbO) and 
deoxygenated hemoglobin (Hb). (C) Graph shows simulated wavelength-dependent effective light 
attenuation coefficient of average soft living tissue. (D) Graph shows contrast-to-noise ratio (CNR) of 
images as function of wavelength including five volunteers (three of five [60%] women with mean age 6 
standard deviation of 26.6 years 6 3.3; two of five [40%] men with mean age of 40.5 years 6 3.5). (E) Graph 
shows statistical difference of CNR was calculated for longer wavelengths (800–900 nm) and shorter 






A study was carried out to assess capabilities of the handheld volumetric multispectral optoacoustic 
tomography (MSOT) approach for noninvasive characterization of healthy human carotid arteries. 
Optoacoustic vascular imaging is associated primarily with optical absorption of blood, whose 
oxygenation status is spectrally distinguished through a multiwavelength imaging approach. The 
handheld volumetric MSOT imaging probe was devised to optimize performance of carotid imaging at 
centimeter-scale depths and to provide an effective field of view of approximately 2 cm3 in real time, 
with the ability to scan further around the area with handheld translation of the probe. The depth of the 
field of view effectively captured by the transducer with respect to the skin can easily be adjusted by 
changing the volume of the acoustic coupling medium, up to a maximum depth of approximately 30 
mm. This is generally sufficient to visualize the carotid bifurcation area in most patients. Light 
attenuation may eventually be the main factor to limit the achievable depth, even if the transducer can 
potentially be redesigned to be sensitive to deeper regions. 
We focused on exploiting the above advantages of volumetric MSOT for imaging the carotid 
bifurcation, an important reference point for atherosclerotic vascular disease. Multispectral imaging 
was further carried out in the near-infrared window with the best image contrast from the carotid artery 
achieved at 1064 nm and the 800–900-nm range due to an increase of the extinction coefficient of 
oxygenated haemoglobin for longer wavelengths and the low light attenuation by tissues in this range. 
Better visibility of deeper arteries was achieved with the 1064-nm excitation, which can be ascribed to 
the higher per-pulse energy of the laser and weaker light attenuation at this wavelength. The 
spectroscopic differentiation capacity is needed for identification of other carotid artery disease 
biomarkers, as well as extrinsically administered targeted or activatable labels (Razansky et al., 2012). 
Efforts in carotid plaque imaging are also geared toward noninvasive detection of vulnerable lipid-rich 
plaques (Finn et al., 2010; Kruizinga et al., 2014). In this context, optoacoustic lipid detection at 1200 
nm has already been demonstrated ex vivo and in preclinical intravascular studies in vivo (Allen et al., 
2012; Jansen, Van Soest, & van der Steen, 2014; Kruizinga et al., 2014). Thus, the suggested handheld 
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volumetric MSOT approach holds promise for rapid volumetric assessment and spectroscopic 
characterization of the carotid artery and plaque vulnerability in a non-invasive manner. Multispectral 
imaging at a more extended spectral range with proper selection of wavelengths within a broader range 
of 650–1250 nm can enable resolving haemoglobin, lipid, and water contributions in the optoacoustic 
images. To detect vulnerable plaque, the carotid artery must first be anatomically identified in single-
wavelength images (eg, at 1064 nm) and once located, multispectral imaging at around 1200 nm may 
help to further identify lipid content, which represents a key factor in vulnerable plaques. 
The real-time three-dimensional imaging capacity of volumetric MSOT presents a key advantage of the 
suggested handheld imaging approach pertaining to visualization of the carotid anatomy, including the 
common carotid artery, internal carotid artery, and external carotid artery that are simultaneously 
captured in a single volumetric image frame. The technique allows three-dimensional volume rendering 
with a single laser shot without signal averaging or probe scanning. This decreases motion-related 
artefacts associated with temporal and spatial blurring. In contrast, clinical US diagnostics typically rely 
on two-dimensional cross-sectional views where multiple alternations between the transverse and 
sagittal planes are necessary for comprehensive assessment of the entire region of interest. 
Several limitations were encountered in this study, among which the most prominent was the lack of 
patient data. This prevents proper quantification of clinically relevant biomarkers (eg, lipid content) that 
can only be assessed after studies in patients with carotid artery disease are performed. We also note 
that US images may provide more detailed anatomic information in some cross-sectional views, with 
the underlying reason being the fundamentally different contrast delivered by the two modalities. 
Optoacoustics also have generally lower penetration depth due to strong light attenuation in living 
tissues, which may have contributed to the lack of detail from deeper tissues layers. In particular, strong 
light absorption by whole blood may impose additional visibility constraints (Xosé Luís Deán-Ben & 
Razansky, 2016)when imaging large blood vessels such as the carotid artery. The unique real-time 
volumetric imaging capacity of optoacoustics can potentially be integrated with US for a more 
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comprehensive characterization of the carotid artery by means of a hybrid imaging probe, as was 
recently shown for the two-dimensional imaging case (Merčep, Deán-Ben, & Razansky, 2018). 
In summary, these results demonstrate the potential of volumetric multispectral optoacoustic 
tomography (MSOT) for spectroscopic volumetric characterization of the carotid artery in a non-
invasive, real-time, and handheld manner. Volumetric MSOT is less prone to motion artefacts than are 
the conventional imaging methods used in clinical practice. Spectroscopic optoacoustics have the 
potential for label-free identification and assessment of clinically relevant biomarkers. As a result, 





Cardiovascular disease is an ongoing worldwide threat, persistently challenging clinicians, scientists 
and the economy. This highlights the need for continuous research in all aspects of CVD, from basic to 
translational approaches. Biomedical imaging has become an indispensable tool in CVD research as it 
is a solution to visualise healthy and diseased biological processes in vivo, which are otherwise not 
possible. Optoacoustic imaging is now emerging as a potential key tool in CVD research and CVD 
diagnostics. Here we show OAT applied both in preclinical and clinical settings to demonstrate its 
capabilities as a multiscale and multidisciplinary imaging device suitable to the cardiovascular field.   
5.1 Murine heart imaging   
Imaging of the murine heart has long been challenging due to its small size and rapid heartbeat 
compared to the human heartbeat. Many studies must rely on histopathological data taken at different 
time points during the course of the disease. However, the adaptation of clinical US and MRI machines 
towards a more preclinical environment accounting for smaller size, has accelerated in vivo basic 
research studies and has become instrumental to translational research. Here we have presented a 
preclinical OAT device, tailored specifically towards the small size of the mouse and its fast heartbeat. 
Building upon studies where OAT of the heart was first shown in real-time and 3D (Xosé Luís Deán-
Ben et al., 2015) along with the extraction of functional parameters such as the PTT, we applied the 
novel cardiovascular imaging tool to CVD models and explored how OAT can identify characteristics 
of heart disease by employing its 4D advantages.   
5.1.1 Myocardial infarction imaging  
Myocardial infarction is highly prominent globally and much of CVD research is focused on post-MI 
treatment to address myocardial remodelling, which imposes long-term effects on heart function after 
the MI event. MI varies in many ways, for example, the length of time the coronary artery is occluded, 
the size of the occlusion, course and speed of treatment and the general health status of the patient. It is 
thus particularly difficult to model these different scenarios pre-clinically. Yet, it is crucial to explore 
models mimicking different clinical scenarios to broaden the understanding of myocardial function post 
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MI. Here we have studied two different surgical models of MI, PO and I/R, and compared both in wt 
mice in addition to exploring the effects of c-kit deficiency in PO models.  The results presented in 
these studies have several implications. Firstly, VOT is capable of detecting differences in myocardial 
function post MI at a mechanical level (PO vs I/R) and also indirectly at a molecular level (c-kit deficient 
vs wt). Therefore, subtle changes at the cellular level that translate into changes at the organ level are 
measurable by VOT in addition to visualising the heart in vivo and in real-time. Although VOT is not 
currently feasible for clinical implementation, the findings can still be used as a basis for studies in the 
clinics. MRI and US imaging of the PTT has recently been shown in humans (Monahan et al., 2019; 
Shors et al., 2003). An interesting future study would be the assessment of PTT values prior to the MI 
event, as the lead up to acute MI is a chronic process, beginning as early as childhood (Hong, 2010). 
However chronic development of atherosclerotic arteries is relevant in human pathophysiology, while 
mice on the other hand are relatively resistant to plaque formation in coronary arteries, thus making it 
challenging to model a highly relevant clinical scenario in mice (von Scheidt et al., 2017). However, 
there are atherosclerotic mouse models that encompass human risk factors, such as modified versions 
of the ‘western diet’ in addition to the more common genetic knockout atherosclerotic models. All in 
all, the mouse models have been indispensable to translational CVD research, even though direct 
comparisons sometimes cannot be made  (Lee et al., 2017).  
The past few decades have seen increased efforts for stem cell regeneration as a treatment method for 
MI. Promising results in preclinical settings were accelerated into the clinical trials, however produced 
inconsistent results leading to a reduction of myocardium regeneration attempts in the cardiac stem cell 
field (Zhou & Wu, 2018). However, it is still important to further investigate the field of research. 
Instead of addressing these questions directly at the molecular level, we explored a model deficient in 
the tyrosine receptor kinase, c-kit, and indirectly assessed the effects of the lack of c-kit on myocardial 
function post MI. The results supported the concept that cardiac progenitor cells are involved in 
myocardial healing post MI, whereby VOT was capable of detecting effects of molecular and genetic 
changes at the organ level. However, the translatability of these results into the clinics still remains 
unclear and more studies must be carried out. For example, contrast agents targeting specific cardiac 
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stem cell markers could help delineate their pathway following MI. Given that the contrast agents would 
be designed for OA imaging, VOT could become a key player as an in vivo imaging system used to 
answer the unresolved CVD questions.   
5.1.2 Pulmonary hypertension imaging 
We have shown the capability of VOT being used as a pre-clinical imaging device to study murine 
models of myocardial infarction. However, in order to establish VOT as a CVD pre-clinical imaging 
modality, it was vital to be tested in other heart disease models. Here we used VOT to assess heart 
function in chronic hypoxic models, where models under chronic hypoxic conditions presented 
impaired heart function compared to control mice under normal conditions. Having used the same 
experimental methods and analytical parameters as in MI imaging, we were able to find a strong 
difference in heart function between the models. These findings strengthen our view that VOT is a 
suitable and advanced imaging tool to study a variety of diseases. What is further attractive about this 
study is that it is a multi-systemic study i.e. two major biological systems are being addressed, the 
cardiovascular and pulmonary systems. The first pathological signs in response to low oxygen levels 
are initially present in the lungs, followed by secondary pathological events in the heart. It is important 
to understand how a disease systematically effects the body and VOT could be an ideal imaging device 
to investigate heart function and how it responds to varying diseases. For example, it is known that heart 
failure risk is significantly increased in diabetic patients (Rosano, Vitale, & Seferovic, 2016). Therefore, 
it is possible that VOT can detect early signs of heart failure in diabetic mouse models, which could 
potentially give rise to new insights into the cardiac-renal interactions.  
5.2 Carotid artery imaging  
The goal of many developing biomedical imaging technologies is their translation into the clinics for 
imaging human pathologies. The human body is on a much grander scale compared to small animal 
imaging, therefore understanding the strengths and limitations of the imaging system is necessary for 
clinical imaging, in order to focus directly on the clinical question which your device could help answer. 
For OAT, the main factors to consider are the optical absorbance properties of the tissue and the 
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accessibility of the tissue i.e. depth of ROI. Having assessed these parameters, the carotid artery in its 
healthy and atherosclerotic state is a prime imaging target for OAT.  
Here we have shown a new approach to imaging the CA, in a non-invasive, real-time and volumetric 
manner. The ease of the handheld scanning capabilities of the probe allow for efficient detection of the 
CA bifurcation. The entire CA bifurcation can be captured in a single volumetric frame, compared to 
conventional US where the probe is often switched between longitudinal and axial planes for better 
understanding of the anatomical location.  However, the most promising conclusion of the presented 
pilot study, is the potential of the OAT handheld probe for stroke prevention. The multispectral nature 
of OAT allows for rapid wavelength switching while imaging live; therefore, allowing the clinician to 
firstly locate the CA bifurcation (850-900nm) and rapidly switch wavelengths where lipids absorb light 
(1200nm) for vulnerable plaque detection. Although the presented work does not demonstrate plaque 
detection as it was carried out in healthy volunteers, several OA studies have demonstrated 
unambiguous detection of lipid content within plaque at 1200nm (Allen et al., 2012; B. Wang et al., 
2012). The use of OAT as an additional screening modality alongside US could become indispensable 
to CA screening for stroke prevention. The current gold standard, US and colour Doppler US, are 
extremely powerful in detecting arterial stenosis. However, characterisation of plaque vulnerability, 
which is often performed by estimating the echogenicity of the suspected plaque region has high inter-
user variability and is an estimation-at-best of the vulnerability of the plaque. OAT can offer an accurate 
reading as it specifically targets lipid tissue composition. OAT could have the benefit to guide surgical 
decisions and reduce the number of unnecessary interventions, improving patient safety and decreasing 
economic burden.  
5.3 Future directions 
Cardiovascular OAT is on route to becoming recognised as both a pre-clinical small animal imaging 
platform and a clinical imaging device for CA screening. However, for this to be achieved, a 
multidisciplinary team is critical. Coordination between engineers, biologists and medical doctors is 
essential for CVD research, so that unsolved problems can be addressed with novel and advanced 
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technological approaches. Therefore, the future of cardiovascular OAT lies in collaborative efforts 
between bioengineers and doctors. OAT has a strong potential in becoming a standard pre-clinical tool 
for imaging models of CVD, especially by focusing on its strength on imaging the murine heart, but in 
order to do so, more disease models in which heart function is suspected to be impaired are necessary. 
Future studies with collaborators with expertise in CVD will help push OAT as a standard imaging 
platform for heart research. 
 Current studies have been focusing on the optimisation of technical parameters, particularly light 
delivery through the transducer to the ROI (Figure 5.1A). By increasing the number of fibre bundles  
from a single-fibre bundle, a larger area can be illuminated thus increasing the FOV (Figure 5.1B). In 
addition, the larger illuminated area increases the permissible pulse energy level therefore has potential 
for deeper tissue imaging. Figure 5.1 C&D represent 3D computer aided design (CAD) prototypes of 
holders for such fibre bundles. The holder is designed in such a way to contain the acoustic coupling 
while also supporting illumination from the fibre bundles. Multi-fibre illumination has the potential to 
improve all areas of OAT and is likely to be implemented in many future studies.  
Figure 5.1 Single and multi-fibre designs for illumination. (A) Hemispherical OAT transducer. (B) Single-
fibre bundle (left panel), multi-fibre bundle (right panel). (C) CAD prototype of holder for single-fibre use (D) 
CAD prototype of holder for multi-fibre use. (OAT; optoacoustic tomography, CAD; computer aided design) 
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OAT as a clinical imaging device is becoming very apparent. In fact, clinical studies to image patients 
at risk of stroke are currently in the pipeline, using the commercial version of OAT (MSOT Acuity, 
iThera Medical GmbH). Planned future clinical studies will implement the custom-designed volumetric 
handheld probe presented in this thesis (Figure 3.1A). Clinical studies for stroke prevention with OAT 
are now closer to reality, rather than a long-term goal. In addition to imaging of the CA clinically, the 
handheld OAT system is capable of imaging multiple diseases on a clinical level, including breast 
cancer, effects of radiation and haemodynamic responses to organ transplants. The increasing number 
of high impact successful clinical studies (Knieling, 2017; Regensburger et al., 2019) and increasing 
number of OAT devices located in hospitals globally, will highlight  OAT as a clinical imaging device. 
With continuous technical development and collection of large volumes of clinical data, OAT has the 
potential to become a standard medical instrument across hospitals in the next few decades.  
Overall, OAT has been shown to be an effective imaging device for CVD applications in pre-clinical 
and clinical research. By utilising its non-invasive, real-time, volumetric and multispectral capabilities, 
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